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ABSTRACT
Lang, Zhaobo Ph.D., Purdue University, December 2014. Identification and charac-
terization of factors involved in DNA demethylation and anti-silencing in Arabidopsis
. Major Professor: Jian-Kang Zhu Professor.
DNA methylation is a key epigenetic mark for transcriptional gene silencing in
many eukaryotes. DNA methylation status can be dynamically controlled by methy-
lation and active demethylation processes. Compared to the well-known mechanisms
of DNA methylation, the mechanisms of DNA demethylation and its regulation are
poorly understood. In order to better understand the DNA demethylation pathway,
we developed two genetic screening systems in Arabidopsis to identify new compo-
nents involved in the DNA demethylation. In the first system, which is based on 35S
promoter driven SUC2 (sucrose transporter 2) transgene, a mutant (91-1 ) was iso-
lated and map-based cloning identified the responsible gene as MBD7 (methyl-CpG
binding protein 7). As important interpreters of DNA methylation, Methyl-CpG-
Binding Domain (MBD) proteins are known to be involved in gene silencing through
recruitment of transcriptional repressors and protein factors for heterochromatin for-
mation. Our data show that Arabidopsis MBD7 functioins as a cellular anti-silencing
factor. MBD7 is required for the expression of transgenes by preventing DNA hy-
permethylation at the transgene promoter. Analysis of the methylome of mbd7 mu-
tant plants revealed that MBD7 prevents DNA hypermethylation at thousands of
genomic loci. MBD7 have been characterized previously as methyl-CpG-binding pro-
teins in vitro, but its in vivo binding targets are not known. We performed chromatin
immunoprecipitation-sequencing (ChIP-seq) experiments to characterize the genome-
wide binding targets of MBD7 in plants. We found that MBD7 preferentially binds
to loci with dense and high levels of mCG. This binding is associated with the role
xvi
of MBD7 in preventing the spread of DNA methylation. Protein interaction assays
revealed that MBD7 is physically associated with other anti-silencing factors such as
IDM1 (Increased DNA methylation 1), IDM2, and IDM3. In fact, MBD7 interacts
directly with the alpha-crystallin domain proteins IDM2 and IDM3. IDM1 (a his-
tone H3 acetyltransferase) and IDM2 are known to function as regulatory factors for
ROS1, a methylcytosine DNA glycosylase/lyase critical for active DNA demethyla-
tion. Our results suggest that MBD7 binds to genomic regions with dense and highly
methylated CGs and prevents the spread of DNAmethylation by recruiting other anti-
silencing factors such as regulators and enzymes for active DNA demethylation. The
second system is based on the RD29A promoter-driven LUC (Luciferase) transgene.
Previous studies in our lab have identified two important mutants from this system,
including ros (repressor of silencing) 1 and ros3. ROS1 is the first DNA demethylase
identified, and ROS3 is a regulatory component in the active DNA demethylation
pathway. In the current study, we carried out an enhancer mutant screen in the ros3
background and isolated and characterized a mutant, rte1 (ros three enhancer 1).
Our results suggest that RTE1 is a novel factor involved in the regulation of active
DNA demethylation.
11. INTRODUCTION
1.1 DNA methylation mechanism
Epigenetics refers to any changes in chromatin status that leads to a modifica-
tion in gene expression without alteration in DNA sequence [1]. As one of the most
important epigenetic marks, DNA methylation is a biochemical process that involves
the addition of a methyl group to the 5th position of the cytosine pyrimidine ring,
forming 5-methylcytosine (5mC) [2]. DNA methylation is often considered a repres-
sive epigenetic mark [2]. In mammals and plants, epigenetic regulation is essential
for many biological processes, such as gene silencing, imprinting, and X chromosome
inactivation [2]. The investigation of epigenetic modification also has important ap-
plied value. In humans, for instance, aberrant DNA methylation occurs in tumor
cells, and DNA methylation markers have been developed for detecting cancer and
for monitoring the development of cancer [3,4]. Moreover, the reversible modification
of DNA methylation provides an opportunity for epigenetic cancer therapy [5, 6]. In
plants, epigenetic modifications play important roles in development, stress response,
polyploidy, and hybrid vigor [7,8]. The manipulation of epigenetic modification may
enable researchers to improve plant productivity and adaptability to the environ-
ment [7–9].
Based on DNA sequence contexts, methylation of cytosine can be classified into
mCG, mCHG, and mCHH (H is C, A, or T). Although mammalian DNA methyla-
tion predominantly occurs in CG context, recent studies have identified some non-CG
methylation in stem cells and mouse brains [10–12]. In contrast, plant cytosine methy-
lation occurs in all three DNA sequence contexts. In Arabidopsis thaliana, the most
abundant type of methylation is mCG, which represents 55% of the total methylated
cytosines, while CHG and CHH represent 23 and 22%, respectively [13]. Like CHG
2and CHH methylation, CG methylation preferentially targets transposons and repet-
itive DNA sequences, although CG methylation is also found to be enriched in some
gene coding regions [13,14].
In plants, the DNA methylation status is dynamically controlled by DNA methy-
lation and DNA demethylation processes [15]. DNA methylation occurs through
two processes: the establishment of DNA methylation and the maintenance of DNA
methylation. The establishment of DNA methylation is mediated by small interfering
RNAs (siRNAs), and the process is designated as RNA-directed DNA methylation
(RdDM) [16]. In the RdDM pathway, small interfering RNAs guide de novo DNA
methylation to complementary genetic loci. Biogenesis of most siRNAs depends on
the plant-specific DNA-dependent RNA polymerase IV (Pol IV) [16]. DTF1 (DNA-
binding transcription factor) / SHH1 (Sawadee homeodomain homolog 1) interacts
with Pol IV in vivo [17,18], and the abolishment of Pol IV occupancy in the dtf1 mu-
tant indicated a role of DTF1 in targeting Pol IV [18]. Another chromatin remodeling
protein, CLSY1 (CLASSY I), functions with Pol IV and DTF1, and is also required
for siRNA biogenesis [18, 19]. Then, RDR2 (RNA-dependent RNA polymerase II)
synthesizes double-stranded RNAs, which are cleaved into 24-nt siRNAs by DCL3
(Dicer-like 3) [20]. After modification by HEN1 (HUA ENHANCER 1), the siRNA
turns into mature siRNA [21]. Mature siRNAs can be loaded into AGO4 and its
closely related agonaute proteins, forming agonaute-siRNA complexes, which are later
recruited to RdDM loci through base pairing between siRNAs and non-coding scaffold
RNA transcripts. Recent studies showed that Pol II and another plant-specific DNA-
dependent RNA polymerase, Pol V, can generate long, non-coding RNA transcripts at
RdDM target loci, which may function as scaffolds for recruiting complementary siR-
NAs [22,23]. A protein complex comprised of DRD1 (defective in RNA-directed DNA
methylation 1), DMS3 (defective in meristem silencing 3), and RDM1 (RNA-directed
DNA methylation 1) is involved in the production of Pol V-dependent non-coding
RNA transcripts [16, 24]. After siRNA biogenesis and siRNA-scaffold RNA pairing,
DRM2 is recruited to catalyze de novo DNA methylation. KTF1 (KOW domain-
3containing transcription factor 1) is capable of binding both the scaffold RNAs and
AGO4, thereby reinforcing the recruitment of the AGO-siRNA complexes to RdDM
target loci [25]. The pre-mRNA splicing factor ZOP1 (zinc finger and OCRE domain
containing Protein 1) is required for silencing some of the RdDM target loci and for
accumulating some Pol IV-dependent 24-nt siRNAs, although ZOP1 is not directly
involved in siRNA biogenesis. Analysis of siRNA accumulation in the zop1 mutant
suggested that ZOP1 might function downstream of the siRNA biogenesis step in the
RdDM pathway [26].
Once established, the DNA methylation pattern must be maintained after DNA
replication during cell division. The methylation in CG and CHG can be maintained
because CG and CHG sequences are symmetrical. The methylation of CHH, however,
cannot be maintained and must be regenerated after each DNA replication because
the CHH sequence is asymmetrical. In plants, the maintenance methylation at CG
context is catalyzed by DNA METHYLTRANSFERASE I (MET1) [27]. After a
round of DNA replication, one fully methylated CpG site becomes two hemimethy-
lated CpG sites, which can serve as substrate for MET1. Rather than fully- or
un-methylated CpG, the hemimethylated CpG site is recognized and bound by VIM1
(VARIANT IN METHYLATION 1), and VIM1 has been shown to be essential for
maintaining CpG methylation in vivo [28, 29]. CG maintenance methylation is also
influenced by DDM1 (decrease in DNA methylation 1), a chromatin remodeling pro-
tein, and the absence of DDM1 results in hypomethylation not only in CG context but
also in CHG and CHH contexts [30,31]. DDM1 is thought to provide an environment
that makes chromatin accessible to DNA methyltransferases [31].
Maintenance of CHG methylation is catalyzed by CMT3 (CHROMOMETHY-
LASE 3) [32]. According to recent research, two other proteins regulate the methy-
lation at CHG sites through their histone-modification activities. One is KRYP-
TONITE (KYP/SUVH4), a histone H3 lysine 9 (H3K9) methyltransferase. CHG
methylation by CMT3 relies on the physical interaction between CMT3 and H3K9me2,
and CHG methylation is decreased in the kyp mutant [33]. The other protein known
4to affect CHG methylation levels is the jmjC domain-containing protein IBM1 (In-
crease in Bonsai Methylation 1). IBM1 can negatively regulate CHG methylation
through its H3K9 demethylase activity [34].
As noted, the DNAmethylation in the CHH context cannot be maintained because
of its asymmetric nature [2]. To date, two pathways responsible for CHH methylation
have been identified: the RNA-dependent-DNA methylation (RdDM) pathway and
the RdDM-independent pathway. In contrast to RdDM, which is guided by siRNAs
and catalyzed by DRM2, RdDM-independent CHH methylation is guided by specific
chromatin environment and is catalyzed by CMT2 (CHROMOMETHYLASE 2) [31].
The recruitment of CMT2 to its target loci depends on the chromatin environment
provided by DDM1. This RdDM-independent CMT2-mediated CHH methylation
pathway is thought to account for most instances of CHH methylation [31].
1.2 DNA demethylation mechanism
The DNA methylation status is dynamically regulated during biological pro-
cesses [2] and in addition to being established and maintained, it can also be re-
moved. In contrast to the well-established DNA methylation pathway, the mechanism
of DNA demethylation is less understood. DNA demethylation can be either passive,
active, or a combination of both. Passive DNA demethylation is caused by inhibition
or lack of DNA maintenance activities during cycles of replication, whereas active
DNA demethylation requires specific enzymatic reactions [2]. A class of glycosy-
lase/lyases has been identified as DNA demethylases, and these include ROS1/DML1
(REPRESSOR OF SILENCER 1/DEMETER LIKE 1), DME (DEMETER), DML2
(DEMETER LIKE 2), and DML3 (DEMETER LIKE 3). Based on the activities
of these enzymes, researchers initially inferred that active DNA demethylation relies
on the base excision repair mechanism [35]. The first DNA demethylase identified
was ROS1 [36]. Mutations in ROS1 caused transcriptional silencing of a transgene
and its homologous endogenous gene. Biochemical evidence was later presented that
5the 5-methylcytosine, instead of only the methyl group, was removed from DNA
through the glycosylase activity of ROS1 [37].Three other enzymes (DME, DML2,
and DML3) in the same family as ROS1 were determined to be also involved in DNA
demethylation [2]. In particular, DME plays an important role in gene imprinting in
plants. Expression of DME in the central cell before double fertilization is required
for maternal allele demethylation and gene imprinting in the endosperm [38, 39]. A
recent study found that DME is expressed in the vegetative cell but not in sperm
cells in the male gametophyte and that DME is important for male fertility [40].
After methylcytosine is removed from DNA and the lyase activity of ROS1 cleaves
the DNA background at the abasic site, the single-nucleotide gap must be filled with
an unmethylated cytosine. ZDP (Arabidopsis thaliana zinc finger DNA 3’ phospho-
esterase), a DNA 3’ phosphatase, removes the phosphate group from the 3’-end of
the gap, resulting in a 3’-hydroxyl terminus that is necessary for the subsequent DNA
repair process [41]. In addition to these enzymes, ROS3 (Repressor of Silencing 3)
was identified as an essential regulator of DNA demethylation [42]. ROS3 contains
an RNA-recognition motif and is a small RNA-binding protein. Co-localization data
and analysis of zdp/ros1 and ros1/ros3 double mutants suggested that ZDP, ROS1,
and ROS3 might function in the same genetic pathway [41,42].
1.3 Genetic systems for studying DNA demethylation
Compared to the well-known mechanisms of DNA methylation and its regulation,
the mechanisms of DNA demethylation and its regulation are poorly understood and
require more research. To identify new components involved in the DNA demethyla-
tion pathway, we developed two genetic screening systems in Arabidopsis.
The first system was developed using the Col-0 ecotype of Arabidopsis. Three
transgenes exist in the wild-type (WT) transgenic plants, including the cauliflower
mosaic virus 35S promoter-driven sucrose transporter 2 (SUC2 ), the double 35S
promoter-driven neomycin phosphotransferase II (NPTII ), and the double 35S promoter-
6driven hygromycin phosphotransferase II (HPTII ). The transgenic plants are very
sensitive to sucrose and show a short-root phenotype on sucrose medium due to the
over expression of the SUC2 transgene. The expression of the SUC2 transgene can
be silenced by DNA hypermethylation at the 35S promoter region [43,44]. To identify
factors involved in DNA demethylation, we mutagenized WT transgenic plants with
EMS and screened for mutants in the M2 population with a long-root phenotype,
which might be caused by silencing of the SUC2 transgene. In this study, a mu-
tant (91-1 ) was isolated that displayed the long-root phenotype on sucrose growth
medium. Through genetic mapping, this mutant was identified as a new recessive
allele of MBD7 (methyl-CpG binding protein 7) and will be described in Chapter 2.
The second genetic screening system was developed using the C24 ecotype of Ara-
bidopsis. Two transgenes were introduced into C24 plants: the RD29A promoter-
driven firefly luciferase reporter gene (proRD29A::LUC ), and the 35S promoter-
driven NPTII gene (35S::NPTII ). The stress-responsive RD29A promoter can be
induced by salt, cold, or ABA treatments. This transgenic line has been very stable
for many generations over the last 17 years. This system has been used to screen for
mutants with higher or lower levels of stress-induced expression of the proRD29A-
LUC transgene. ros1 and ros3 mutants were both screened from this system [36,42].
In the current project, we initiated a screen for genetic enhancers in the ros3 mutant
background. Based on luminescence phenotype, a ros3 enhancer mutant, rte1 (ros
three enhancer 1), was identified and characterized as described in Chapter 3.
1.4 References
[1] Chiara Raggi and Pietro Invernizzi. Methylation and liver cancer. Clinics and
Research in Hepatology and Gastroenterology, 37(6):564–571, December 2013.
[2] Jian-Kang Zhu. Active DNA demethylation mediated by DNA glycosylases.
Annual review of genetics, 43:143–166, 2009.
[3] Ahmad Besaratinia, Myles Cockburn, and Stella Tommasi. Alterations of DNA
methylome in human bladder cancer. Epigenetics : official journal of the DNA
Methylation Society, 8(10):1013–1022, October 2013.
7[4] Ewa Brzezian´ska, Agata Dutkowska, and Adam Antczak. The significance of epi-
genetic alterations in lung carcinogenesis. Molecular Biology Reports, 40(1):309–
325, October 2012.
[5] Marko Jakopovic, Anish Thomas, Sanjeeve Balasubramaniam, David Schrump,
Giuseppe Giaccone, and Susan E Bates. Targeting the Epigenome in Lung Can-
cer: Expanding Approaches to Epigenetic Therapy. Frontiers in oncology, 3:261,
2013.
[6] Tim J Wigle and Robert A Copeland. Drugging the human methylome: an
emerging modality for reversible control of aberrant gene transcription. Current
opinion in chemical biology, 17(3):369–378, June 2013.
[7] Danny W-K Ng, Jie Lu, and Z Jeffrey Chen. Big roles for small RNAs in
polyploidy, hybrid vigor, and hybrid incompatibility. Current opinion in plant
biology, 15(2):154–161, April 2012.
[8] Xiangsong Chen and Dao-Xiu Zhou. Rice epigenomics and epigenetics: chal-
lenges and opportunities. Current opinion in plant biology, 16(2):164–169, May
2013.
[9] Z Jeffrey Chen. Genomic and epigenetic insights into the molecular bases of
heterosis. Nature Reviews Genetics, 14(7):471–482, June 2013.
[10] Ryan Lister, Mattia Pelizzola, Robert H Dowen, R David Hawkins, Gary Hon,
Julian Tonti-Filippini, Joseph R Nery, Leonard Lee, Zhen Ye, Que-Minh Ngo,
Lee Edsall, Jessica Antosiewicz-Bourget, Ron Stewart, Victor Ruotti, A Har-
vey Millar, James A Thomson, Bing Ren, and Joseph R Ecker. Human DNA
methylomes at base resolution show widespread epigenomic differences. Nature,
462(7271):315–322, November 2009.
[11] Wei Xie, Cathy L Barr, Audrey Kim, Feng Yue, Ah Young Lee, James Eu-
banks, Emma L Dempster, and Bing Ren. Base-resolution analyses of sequence
and parent-of-origin dependent DNA methylation in the mouse genome. Cell,
148(4):816–831, February 2012.
[12] Michael B Stadler, Rabih Murr, Lukas Burger, Robert Ivanek, Florian Lienert,
Anne Scho¨ler, Erik van Nimwegen, Christiane Wirbelauer, Edward J Oakeley,
Dimos Gaidatzis, Vijay K Tiwari, and Dirk Schu¨beler. DNA-binding factors
shape the mouse methylome at distal regulatory regions. Nature, 480(7378):490–
495, December 2011.
[13] Ryan Lister, Ronan C O’Malley, Julian Tonti-Filippini, Brian D Gregory,
Charles C Berry, A Harvey Millar, and Joseph R Ecker. Highly integrated single-
base resolution maps of the epigenome in Arabidopsis. Cell, 133(3):523–536, May
2008.
[14] Xiaoyu Zhang, Junshi Yazaki, Ambika Sundaresan, Shawn Cokus, Simon W L
Chan, Huaming Chen, Ian R Henderson, Paul Shinn, Matteo Pellegrini, Steve E
Jacobsen, and Joseph R Ecker. Genome-wide high-resolution mapping and func-
tional analysis of DNA methylation in arabidopsis. Cell, 126(6):1189–1201,
September 2006.
8[15] Xin-Jian He, Taiping Chen, and Jian-Kang Zhu. Regulation and function of
DNA methylation in plants and animals. Cell research, 21(3):442–465, March
2011.
[16] Huiming Zhang and Jian-Kang Zhu. RNA-directed DNA methylation. Current
opinion in plant biology, 14(2):142–147, April 2011.
[17] Jun Liu, Ge Bai, Cuijun Zhang, Wei Chen, Jinxing Zhou, Suwei Zhang, Qing
Chen, Xin Deng, Xin-Jian He, and Jian-Kang Zhu. An atypical component
of RNA-directed DNA methylation machinery has both DNA methylation-
dependent and -independent roles in locus-specific transcriptional gene silencing.
Cell research, 21(12):1691–1700, November 2011.
[18] Heng Zhang, Ze Yang Ma, Liang Zeng, Kaori Tanaka, Cui Jun Zhang, Jun Ma,
Ge Bai, Pengcheng Wang, Su Wei Zhang, Zhang-Wei Liu, Tao Cai, Kai Tang,
Renyi Liu, Xiaobing Shi, Xin-Jian He, and Jian-Kang Zhu. DTF1 is a core
component of RNA-directed DNA methylation and may assist in the recruitment
of Pol IV. Proceedings of the National Academy of Sciences, 110(20):8290–8295,
May 2013.
[19] Lisa M Smith, Olga Pontes, Iain Searle, Nataliya Yelina, Faridoon K Yousafzai,
Alan J Herr, Craig S Pikaard, and David C Baulcombe. An SNF2 protein asso-
ciated with nuclear RNA silencing and the spread of a silencing signal between
cells in Arabidopsis. The Plant cell, 19(5):1507–1521, May 2007.
[20] Zhixin Xie, Lisa K Johansen, AdamMGustafson, Kristin D Kasschau, Andrew D
Lellis, Daniel Zilberman, Steven E Jacobsen, and James C Carrington. Genetic
and functional diversification of small RNA pathways in plants. PLoS biology,
2(5):E104, May 2004.
[21] Zhiyong Yang, Yon W Ebright, Bin Yu, and Xuemei Chen. HEN1 recognizes
21-24 nt small RNA duplexes and deposits a methyl group onto the 2’ OH of the
3’ terminal nucleotide. Nucleic acids research, 34(2):667–675, 2006.
[22] Andrzej T Wierzbicki, Jeremy R Haag, and Craig S Pikaard. Noncoding tran-
scription by RNA polymerase Pol IVb/Pol V mediates transcriptional silencing
of overlapping and adjacent genes. Cell, 135(4):635–648, November 2008.
[23] Binglian Zheng, Zhengming Wang, Shengben Li, Bin Yu, Jin-Yuan Liu, and
Xuemei Chen. Intergenic transcription by RNA polymerase II coordinates Pol
IV and Pol V in siRNA-directed transcriptional gene silencing in Arabidopsis.
Genes & Development, 23(24):2850–2860, December 2009.
[24] Julie A Law, Israel Ausin, Lianna M Johnson, Ajay A Vashisht, Jian-Kang Zhu,
James A Wohlschlegel, and Steven E Jacobsen. A protein complex required for
polymerase V transcripts and RNA- directed DNA methylation in Arabidopsis.
Current biology : CB, 20(10):951–956, May 2010.
[25] Xin-Jian He, Yi-Feng Hsu, Shihua Zhu, Andrzej T Wierzbicki, Olga Pontes,
Craig S Pikaard, Hai-Liang Liu, Co-Shine Wang, Hailing Jin, and Jian-Kang
Zhu. An effector of RNA-directed DNA methylation in arabidopsis is an ARG-
ONAUTE 4- and RNA-binding protein. Cell, 137(3):498–508, May 2009.
9[26] Cui Jun Zhang, Jin Xing Zhou, Jun Liu, Ze Yang Ma, Su Wei Zhang, Kun
Dou, Huan Wei Huang, Tao Cai, Renyi Liu, Jian-Kang Zhu, and Xin-Jian He.
The splicing machinery promotes RNA-directed DNA methylation and transcrip-
tional silencing in Arabidopsis. The EMBO journal, 32(8):1128–1140, April 2013.
[27] N Kishimoto, H Sakai, J Jackson, S E Jacobsen, E M Meyerowitz, E S Dennis,
and E J Finnegan. Site specificity of the Arabidopsis METI DNA methyltrans-
ferase demonstrated through hypermethylation of the superman locus. Plant
molecular biology, 46(2):171–183, May 2001.
[28] Hye Ryun Woo, Travis A Dittmer, and Eric J Richards. Three SRA-domain
methylcytosine-binding proteins cooperate to maintain global CpG methylation
and epigenetic silencing in Arabidopsis. PLoS genetics, 4(8):e1000156, 2008.
[29] Qin Yao, Chun-Xiao Song, Chuan He, Desigan Kumaran, and John J Dunn.
Heterologous expression and purification of Arabidopsis thaliana VIM1 protein:
in vitro evidence for its inability to recognize hydroxymethylcytosine, a rare base
in Arabidopsis DNA. Protein expression and purification, 83(1):104–111, May
2012.
[30] Jeffrey A Jeddeloh, Trevor L Stokes, and Eric J Richards. Maintenance of
genomic methylation requires a SWI2/SNF2-like protein. Nature genetics,
22(1):94–97, May 1999.
[31] Assaf Zemach, M Yvonne Kim, Ping-Hung Hsieh, Devin Coleman-Derr, Leor
Eshed-Williams, Ka Thao, Stacey L Harmer, and Daniel Zilberman. The Ara-
bidopsis nucleosome remodeler DDM1 allows DNA methyltransferases to access
H1-containing heterochromatin. Cell, 153(1):193–205, March 2013.
[32] A M Lindroth. Requirement of CHROMOMETHYLASE3 for Maintenance of
CpXpG Methylation. Science, 292(5524):2077–2080, May 2001.
[33] James P Jackson, Anders M Lindroth, Xiaofeng Cao, and Steven E Jacobsen.
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyl-
transferase. Nature, 416(6880):556–560, March 2002.
[34] Hidetoshi Saze, Akiko Shiraishi, Asuka Miura, and Tetsuji Kakutani. Control
of genic DNA methylation by a jmjC domain-containing protein in Arabidopsis
thaliana. Science, 319(5862):462–465, January 2008.
[35] Teresa Morales-Ruiz, Ana Pilar Ortega-Galisteo, Mar´ıa Isabel Ponferrada-Mar´ın,
Mar´ıa Isabel Mart´ınez-Mac´ıas, Rafael R Ariza, and Teresa Rolda´n-Arjona.
DEMETER and REPRESSOR OF SILENCING 1 encode 5-methylcytosine DNA
glycosylases. Proceedings of the National Academy of Sciences of the United
States of America, 103(18):6853–6858, May 2006.
[36] Zhizhong Gong, Teresa Morales-Ruiz, Rafael R Ariza, Teresa Rolda´n-Arjona,
Lisa David, and Jian-Kang Zhu. ROS1, a repressor of transcriptional gene si-
lencing in Arabidopsis, encodes a DNA glycosylase/lyase. Cell, 111(6):803–814,
December 2002.
[37] Fernanda Agius, Avnish Kapoor, and Jian-Kang Zhu. Role of the Arabidopsis
DNA glycosylase/lyase ROS1 in active DNA demethylation. Proceedings of the
National Academy of Sciences of the United States of America, 103(31):11796–
11801, August 2006.
10
[38] Yeonhee Choi, Mary Gehring, Lianna Johnson, Mike Hannon, John J Harada,
Robert B Goldberg, Steven E Jacobsen, and Robert L Fischer. DEMETER, a
DNA glycosylase domain protein, is required for endosperm gene imprinting and
seed viability in arabidopsis. Cell, 110(1):33–42, July 2002.
[39] T Kinoshita. One-way control of FWA imprinting in Arabidopsis endosperm by
DNA methylation. Science, 303(5657):521–523, January 2004.
[40] Francesca Scebba, Giovanni Bernacchia, Morena De Bastiani, Monica Evange-
lista, Rita Maria Cantoni, Rino Cella, Maria Tereasa Locci, and Letizia Pitto.
Arabidopsis MBD proteins show different binding specificities and nuclear local-
ization. Plant molecular biology, 53(5):715–731, November 2003.
[41] Mar´ıa Isabel Mart´ınez-Mac´ıas, Weiqiang Qian, Daisuke Miki, Olga Pontes, Yun-
hua Liu, Kai Tang, Renyi Liu, Teresa Morales-Ruiz, Rafael R Ariza, Teresa
Rolda´n-Arjona, and Jian-Kang Zhu. A DNA 3’ phosphatase functions in active
DNA demethylation in Arabidopsis. Molecular cell, 45(3):357–370, February
2012.
[42] Xianwu Zheng, Olga Pontes, Jianhua Zhu, Daisuke Miki, Fei Zhang, Wen-Xue
Li, Kei Iida, Avnish Kapoor, Craig S Pikaard, and Jian-Kang Zhu. ROS3 is an
RNA-binding protein required for DNA demethylation in Arabidopsis. Nature,
455(7217):1259–1262, October 2008.
[43] M Lei, H La, K Lu, PWang, D Miki, Z Ren, C G Duan, XWang, K Tang, L Zeng,
L Yang, H Zhang, W Nie, P Liu, J Zhou, R Liu, Y Zhong, D Liu, and J K Zhu.
Arabidopsis EDM2 promotes IBM1 distal polyadenylation and regulates genome
DNA methylation patterns. Proceedings of the National Academy of Sciences,
111(1):527–532, January 2014.
[44] Xingang Wang, Cheng-Guo Duan, Kai Tang, Bangshing Wang, Huiming Zhang,
Mingguang Lei, Kun Lu, Satendra K Mangrauthia, Pengcheng Wang, Guohui
Zhu, Yang Zhao, and Jian-Kang Zhu. RNA-binding protein regulates plant DNA
methylation by controlling mRNA processing at the intronic heterochromatin-
containing gene IBM1. Proceedings of the National Academy of Sciences,
110(38):15467–15472, September 2013.
11
2. A METHYL-CPG-BINDING PROTEIN PREVENTS
THE SPREAD OF DNA METHYLATION AND
TRANSCRIPTIONAL GENE SILENCING BY
RECRUITING FACTORS FOR ACTIVE DNA
DEMETHYLATION
2.1 Abstract
DNA methylation is a key epigenetic mark for transcriptional gene silencing in
many eukaryotes. As important interpreters of DNA methylation, Methyl-CpG-
Binding Domain (MBD) proteins are known to be involved in gene silencing through
recruitment of transcriptional repressors and protein factors for heterochromatin for-
mation. Here, we report the identification of Arabidopsis MBD7 as a cellular anti-
silencing factor. MBD7 is required for the expression of transgenes by preventing
DNA hypermethylation at the transgene promoter. Analysis of the methylome of
mbd7 mutant plants revealed that MBD7 prevents DNA hypermethylation at thou-
sands of transposable elements (TEs) and other genomic loci. In mbd7 mutant plants,
hypermethylation occurs mainly in CHG and CHH sequence contexts (H=A, C, or
T). Among the 13 members of the MBD family of proteins in Arabidopsis, MBD5,
MBD6, and MBD7 have been characterized previously as methyl-CpG-binding pro-
teins in vitro, but their in vivo binding targets are not known. We performed chro-
matin immunoprecipitation-sequencing (ChIP-seq) experiments to characterize the
genome-wide binding targets of MBD7 in plants. We found that MBD7 preferentially
binds to loci with dense and high levels of mCG. This binding is associated with
the role of MBD7 in preventing the spread of DNA methylation. Protein interaction
assays revealed that MBD7 is physically associated with other anti-silencing factors
such as IDM1, IDM2, and IDM3. In fact, MBD7 interacts directly with the alpha-
12
crystallin domain proteins IDM2 and IDM3. IDM1 (a histone H3 acetyltransferase)
and IDM2 are known to function as regulatory factors for ROS1, a methylcytosine
DNA glycosylase/lyase critical for active DNA demethylation. Our results suggest
that MBD7 binds to genomic regions with dense and highly methylated CGs and pre-
vents the spread of DNA methylation by recruiting other anti-silencing factors such
as regulators and enzymes for active DNA demethylation.
2.2 Introduction
In mammals and plants, DNA methylation is important for many epigenetic pro-
cesses, such as gene silencing, imprinting, and X chromosome inactivation [1]. DNA
methylation occurs in three contexts: CG, CHG, and CHH (where H is A, C, or T) in
plants [2]. In addition to DNA methylation, histone modifications such as ubiquitina-
tion, methylation, acetylation, sumoylation, and phosphorylation are also important
epigenetic marks [3, 4]. Histone modifications may create a chromatin environment
that is more or less accessible for transcription. Methylation and acetylation of lysines
in histones are two well-characterized modifications. Previous studies showed that ly-
sine acetylation in histones H3 and H4 correlates with active transcription [4–7].
Researchers have identified some histone acetyltransferases and deacetylases that
catalyze this reversible modification. Identified histone acetyltransferases included
HAG1, HAG3, HAM1, HAC1, and TAF1 [8]. Histone deactylases (HDACs) include
three types of enzymes: RPD3-like superfamily HDACs, HD2-like HDACs, and SIR2
family HDACs [8–10]. IDM1/ROS4, a recently identified histone acetyltransferase,
specifically modifies H3K18 and K3K23 in Arabidopsis. In the idm1 mutant, a trans-
gene is silenced because of a lack of H3K18ac and H3K23ac in the transgene promoter
regions, which leads to DNA hypermethylation of the promoter [7,11]. In contrast to
histone acetylation, methylation of histones can either activate or repress transcrip-
tion. Methylation of H3K4, H3K36, and H3K79 are epigenetic marks for active genes,
whereas methylation of H3K9, H3K27, and H3K20 are marks for inactive genes [3,12].
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DNA methylation and histone modifications are interconnected. For instance,
methylation of CHG by CMT3 relies on the binding of CMT3 to H3K9me2 [13].
MET1, the enzyme catalyzing CG methylation, interacts with the histone deacetyl-
transferase HDA6 in vivo [14]. A histone-binding protein, DTF1/SHH1, specifically
recognizes H3 with methylated K9 and unmethylated K4, and recruits PolIV to ini-
tiate RNA-directed DNA methylation (RdDM) [15–17]. DNA methylation can also
be negatively regulated by H3K4 methylases such as JMJ14, LDL, and LDL2, and
by the histone acetyltransferase IDM1 [7,11, 18].
The epigenetic marks are interpreted by specific proteins to cause downstream
effects. The methyl-CpG-binding domain (MBD) proteins are important interpreters
of DNA methylation. Plant MBD proteins were first characterized by Zemach et
al. in 2003 [19]. This protein family contains 13 putative MBD proteins based
on bioinformatics analysis [19–22]. MBD8, MBD9, and MBD11 were suggested to
be important for normal development in Arabidopsis [22–24]. MBD11 knockdown
mutants displayed aberrant morphological and developmental phenotypes, such as
aerial rosettes, serrated leaves, and reduced fertility [22]. The mutation of MBD8
resulted in a late flowering phenotype due to down regulation of two major promoters
of flowering, FT (flowering locus T) and SOC1 (suppressor of constant 1). The late
flowering phenotype of the mbd8 mutant was observed in the C24 ecotype but not
in the Col-0 ecotype [23]. In contrast to MBD8, MBD9 is a negative regulator of
flowering. MBD9 directly controls flowering time by its histone acetyltransferase
activity. In the mbd9 mutant the acetylation level of histone H3 and H4 on FLC
(flowering locus C) chromatin is dramatically reduced, leading to repressed expression
of the flowering repressor FLC [24, 25]. In addition to MBD9, MBD6 is another
member that is associated with histone modification in vitro [19]. After incubation
with Arabidopsis leaf nuclear extract, the complex immuno-precipitated by GST-
MBD6 possessed a histone deacetylase activity [19]. Although all of these proteins
contain a methyl-DNA-binding domain, only MBD5, MBD6, and MBD7 are capable
of specifically binding to methylated DNA [19,21,26]. Further investigations showed
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that all three members are able to bind to mCpG sites but not to mCHG sites in
vitro and that MBD5 can also bind to mCHH sites. In addition, MBD11 has a DNA-
binding ability independent of DNA methylation status [19]. MBD5 and MBD6 are
capable of binding to DDM1 in vitro [27].
MBD7 is distinguished from all other MBD members by the presence of three
MBD domains [22]. MBD7 contains four functional domains, including the three
MBD domains and a StkC (sticky-c) domain at the C terminus [28]. By using
35S::MBD7-GFP transiently expressed in protoplasts, researchers determined that
MBD7 localizes to all cshromocenters [29]. Localization of truncated MBD7 proteins
suggested that the three MBD motifs are sufficient for chromocenter localization and
that the number of MBD motifs influences MBD7 localization [29]. Although the
StkC domain of MBD7 is not involved in protein localization, it has strong chromatin-
binding activity and may help MBD7 fasten to chromosomal mCpG sites [28]. MBD7
is a substrate for PRMT11 in vitro, but PRMT11 does not influence MBD7 localiza-
tion [30].
In this study, we discovered that MDB7 has a critical role in protecting trans-
genes from transcriptional silencing. MBD7 binds to densely methylated CpG sites
and prevents the spreading of DNA methylation to neighboring regions. We found
that MBD7 interacts with other cellular anti-silencing factors such as IDM3, IDM2
and IDM1 [7,31] . These latter factors are regulators of the DNA demethylase ROS1,
and are thus necessary for active DNA demethylation at many genomic loci. There-
fore, MBD7 interprets DNA methylation not to cause silencing but to prevent DNA
methylation spreading to avoid silencing.
2.3 Results
2.3.1 Mutation in MBD7 causes transgene silencing
We developed a very effective system for screening for Arabidopsis mutants with
enhanced silencing based on root-length phenotype [32,33]. In this system, a 35S::SUC2
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transgene is introduced into Col-0 wild-type (WT) plants. Because of over-expression
of SUC2, the transgenic plants are very sensitive to sucrose, resulting in a short-root
phenotype when grown on sucrose-containing media (Fig.2.1). This system also con-
tains double 35S promoter-driven NPTII and HPTII. If a gene is required for anti-
silencing, its loss-of-function mutation will cause 35S::SUC2 transgene silencing. To
identify anti-silencing factors, we mutagenized WT plants with EMS and screened
the M2 population for mutants with long-root phenotype, a phenotype that indicates
possible silencing of the SUC2 transgene. Our mutant screen has identified several
novel anti-silencing factors, such as Anti-silencing 1 (ASI1), Enhanced Downy Mildew
2 (EDM2). In addition, we identified new mutant alleles of known anti-silencing fac-
tors, such as IDM1 and ROS1 [32,33].
In this study, we characterized a mutant, 91-1, which developed long roots on
sucrose growth medium (Fig.2.1). In addition to having long roots, mutant 91-1
is sensitive to both hygromycin and kanamycin (Fig.2.2), indicating that all three
transgenes might be silenced in this mutant. Results from both Northern blot and
RT-qPCR showed that transcript levels of all three transgenes are lower in 91-1 than
in WT plants (Fig.2.3). Through map-based cloning, we identified the mutant 91-1
as a recessive allele of mbd7 (AT5g59800), hereafter named mbd7-1. A C-to-T point
mutation changed the 18th amino acid of MBD7 to a stop codon (Fig.2.4). To confirm
that the silencing of transgenes was caused by the mutation of MBD7, we crossed
WT with a T-DNA insertion allele of MBD7 (CS876032), mbd7-2, and found that
plants with 35S::SUC2 and homozygous T-DNA insertion in MBD7 also showed the
long-root phenotype (Fig.2.5 and 2.6). In addition, the root phenotype of mbd7-1
could be complemented by native promoter-driven MBD7 full-length genomic DNA
fused with either an MYC tag or a GFP tag (Fig.2.7A). RT-PCR indicated that
proMBD7::gMBD7-4xMYC is able to rescue the suppressed expression of 35S::SUC2
and 35S::HPTII transgenes (Fig.2.7B). Together, these results demonstrate that mu-
tations in MBD7 cause transgene silencing, thereby revealing an anti-silencing role
for MBD7.
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2.3.2 DNA hypermethylation and repressive histone modification accom-
pany the silencing of transgenes
To determine whether silencing of these transgenes occurs at transcriptional levels
in mbd7-1, we examined RNA Polymerase II (Pol II) occupancy on the 35S trans-
gene promoters in mbd7-1. Chromatin immunoprecipitation (ChIP) assays showed
that Pol II occupancy at both 35S::SUC2 and 35S::HPTII promoters is reduced in
mbd7-1 (Fig.2.8), suggesting that the reduced transgene RNA levels are caused by
decreased Pol II transcription. Previous results indicated that silencing of 35S::SUC2
is correlated with alterations in the levels of several histone modifications, including
H3K9me2, H3K18ac, and H3K23ac [7, 11, 32, 33]. Consistent with the decreased Pol
II transcription, ChIP assays showed that, at 35S promoter regions, the repressive
histone mark H3K9me2 is increased in mbd7-1 (Fig.2.9), while the active histone
marks H3K18ac and H3K23ac are reduced in mbd7-1 (Fig.2.10 and 2.11).
In addition to histone modifications, DNA methylation is another important epi-
genetic mark that influences chromatin status and can confer transcriptional silencing.
To investigate whether DNA methylation plays a role in transgene silencing in mbd7-
1, we determined the effect of 5-aza-2’-deoxycytidine (5- aza), a DNA methylation
inhibitor, on the kanamycin resistance of mbd7-1. In the absence of 5- aza treatment,
mbd7-1 was more sensitive than the WT to kanamycin (Fig.2.2). The difference in
kanamycin resistance between the WT and mbd7-1, however, was reduced by 5- aza
treatment, indicating that DNA methylation plays an important role in silencing the
NPTII transgene (Fig.2.2). To examine whether the mbd7-1 mutation affects DNA
methylation, we performed whole-genome bisulfite sequencing for both the WT and
mbd7-1. The DNA methylation level at 35S promoters was greater in mbd7-1 than
in the WT even though the WT already has a high level of DNA methylation at 35S
promoters (Fig.2.12). Together, these results demonstrate that MBD7 dysfunction
causes transcriptional silencing through epigenetic modifications.
17
2.3.3 The mbd7 mutation causes genome-wide DNA hypermethylation
Whole-genome bisulfite sequencing identified 7561 DMRs (differentially methy-
lated regions) in mbd7-1, among which 5694 are hypermethylated, while only 1867
are hypomethylated. In CHG and CHH contexts, the hypermethylated regions are
significantly more abundant than the hypomethylated regions (Fig.2.13). Most hy-
permethylated loci are rich in the mCHH context (Fig.2.13). The much greater num-
ber of hypermethylated regions suggested that MBD7 mainly antagonizes the DNA
methylation pathway.
Ten hypermethylated cytosines (HMC) were selected for validation by Chop-PCR.
Genomic DNA of the WT and mbd7-1 was extracted and digested by methylation-
sensitive endonucleases, such as Hpa II. Subsequently, the digested DNA was used
as template for PCR amplification that covered the restriction sites. The results
confirmed DNA hypermethylation in mbd7-1 and were therefore consistent with the
whole-genome bisulfite sequencing results (Fig.2.14).
For most of the hypermethylated loci, mCHG and/or mCHH were increased (see
the two screenshots on the left of Fig.2.15). mCG methylation was also increased in
some regions (see the 3rd screenshot in Fig.2.15).
We found that about 67% of the hyper-DMRs are located in transposable elements,
22% are located in intergenic regions, and only 11% are in genes and pseudogenes
(Fig.2.16). Among these DMR-associated TEs, the mCG level was not changed while
the mCHG level was slightly increased, and the mCHH level was obviously increased
in the mbd7-1 mutant (Fig.2.17). We then determined whether specific types of TEs
are preferentially influenced. However, a comparison of the compositions of total TEs
in the WT and of MBD7-affected TEs revealed no obvious preference for any specific
type of TE (Fig.2.18). At TEs affected by MBD7, changes of DNA methylation levels
are independent of TE length (Fig.2.19).
In the mbd7-1 mutant, hyper DMRs tend to be distributed near centromeric
and pericentromeric regions (Fig.2.20), indicating that MBD7 might preferentially
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regulate TEs located at pericentromeric regions. To test this possibility, we defined
hypermethylated TE density as the number of hyper DMR-associated TEs divided by
the total number of TEs. Hypermethylated TE density was calculated in consecutive
50-kb windows. Hypermethylated TE density distribution across five chromosomes
showed that there was no obvious preference for centromeric or pericentromeric TEs
(Fig.2.21), suggesting that hypermethylated TEs aggregate around pericentromeric
regions simply because of the high TE density in the regions and not because of a
preference of MBD7 for pericentromeric TEs.
2.3.4 MBD7-binding positively correlates with mCG methylation density
MBD7 was previously shown as a methyl DNA-binding protein [19]. To date,
there has been no report of genome-wide binding targets of MBD7 or any other MBD
proteins in plants. proMBD7::gMBD7-4xMYC transgenic plants were used for ChIP
assays. Western blot analysis showed that the tagged MBD7 protein was expressed,
and the mutant phenotype was complemented, suggesting that the tagged protein
was functional (Fig.2.22 and 2.7). To characterize endogenous MBD7 binding targets,
we performed ChIP against MBD7-4xMYC followed by high throughput sequencing
(ChIP-seq).
We examined the correlation between MBD7 binding and DNA methylation, in-
cluding CG methylation, CHG methylation, and CHH methylation. First, the genome
was divided into 1-kb regions, and MBD7 enrichment was calculated for each region.
The top 1% of the MBD7-enriched regions was selected for further analysis. To eval-
uate the influences of DNA methylation level on MBD7 enrichment, we ranked these
regions by CG, CHG, and CHH methylation level, and generated a heat map of MBD7
enrichment (Fig.2.23). However, no pattern of MBD7 enrichment was evident in all
three ranks, suggesting that methylation level does not determine MBD7 binding.
To consider not only methylation level but also the methyl cytosine density of
one region, we calculated the methylation density for 1-kb windows. Methylation
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density is a value reflecting both methylation level and methyl cytosine frequency
for one region, and it is equal to the sum of methylation percentages of individual
cytosines normalized by region length [34]. When these regions were ranked by mCG,
mCHG, and mCHH methylation density, the heat map pattern indicated that MBD7
enrichment is associated with CG methylation density rather than with CHG and
CHH methylation density (Fig.2.24), which is consistent with the previous finding
that MBD7 can bind to mCG sites but not to mCHG sites in vitro [19]. The analysis
of methylation level and methylation density suggested that regions with dense and
highly methylated mCGs are preferred by MBD7. The tight relationship between
MBD7 enrichment and CG methylation density was also supported by genome-wide
analysis. We ranked genomic 1-kb windows by CG, CHG, and CHH methylation
density, and found that MBD7 enrichment was positively correlated with CG methy-
lation density but not with CHG or CHH methylation density (Fig.2.25). Two regions
were selected to show that the MBD7 could specifically bind to regions with high CG
methylation density (Fig.2.26).
2.3.5 MBD7 binding is associated with the presence of mCHG and mCHH
We identified 2452 MBD7-binding sites through two biological replicates of ChIP-
seq. Of 2452 loci, 1930 (78.7%) are TE regions, 94 (3.8%) are intergenic regions, 401
(16.4%) are genes, and 27 (1.1%) are pseudogenes or others (Fig.2.27). We analyzed
the mCG methylation density of all TE-associated 1-kb windows (TE windows) and
all gene-associated 1-kb windows (gene windows), and found that TE windows gen-
erally have higher CG methylation density than gene windows (Fig.2.28). To test
whether the TE-preferred binding of MBD7 is due to the higher CG methylation
density of TE or due to other TE-specific features, we selected TE windows and gene
windows with comparable CG methylation density and then compared their MBD7
enrichment (Fig.2.29). Analysis of MBD7 enrichment revealed that MBD7 binding
was more associated with high mCG density in TEs than in genes (Fig.2.29); this
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pattern was consistent in all tested ranges of mCG methylation density (Fig.2.30).
We therefore hypothesized that MBD7 may not bind to all regions with high mCG
density but instead binds to regions with high mCG density in specific chromatin
environments.
Although MBD7 binding did not correlate well with CHG or CHH methylation
density, all MBD7 enriched regions appeared to have CHG or CHH methylation
(Fig.2.25). We therefore compared MBD7 enrichment in two types of gene windows
with the same mCG density. Type I windows lacked mCHG and mCHH, and type II
windows had mCHG or mCHH. At comparable mCG methylation densities, MBD7
enrichment was greater in type II windows than in type I windows (Fig.2.31 and
2.32), indicating that MBD7 enrichment is associated with the presence of non-CG
methylation.
In summary, MBD7 enrichment is positively correlated with CG methylation den-
sity but MBD7 binding is also associated with the presence of non-CG methylation.
2.3.6 MBD7 binding influences DNA methylation level
To investigate the correlation of MBD7 binding with its influence on DNA methy-
lation, we calculated MBD7 enrichment and the number of hyper differentially methy-
lated cytosine (DMC) in the mbd7-1 mutant for each 50-kb region. Hyper DMCs were
positively correlated with MBD7 enrichment (Fig.2.33), indicating that DNA hyper-
methylation in mbd7-1 is tightly related to the absence of MBD7 around that region.
A similar correlation exists between MBD7 enrichment and numbers of hyper mCG,
mCHG, and mCHH (Fig.2.34).
To further understand the influence of MBD7 on DNA methylation at its binding
loci, we compared the methylation level of binding loci in both the WT and mbd7-1.
Two groups of control regions were randomly selected, and their methylation levels
were also calculated. In mbd7-1, mCHG and mCHH methylation levels were elevated
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at MBD7-binding regions but not in control regions (Fig.2.35). The mCGmethylation
level increased slightly at MBD7-binding regions.
These findings were supported by a closer examination of transgene regions. At
the 35S::SUC2 locus, ChIP-seq results showed that MBD7 proteins were enriched in
the 35S promoter, which was also hypermethylated in the mbd7-1 mutant (Fig.2.36).
Binding of MBD7 to the 35S promoter was also confirmed by individual MBD7 ChIP-
qPCR (Fig.2.37). Four endogenous MBD7-binding regions were selected to show
that DNA methylation at MBD7-binding loci was increased in the mbd7-1 mutant
(Fig.2.38).
2.3.7 MBD7 interacts with other anti-silencing factors
To identify MBD7-interacting proteins, we used proMBD7::MBD7-4xMYC trans-
genic plants and performed immuno-precipitation (IP) followed by LC-MS (liquid
chromatography-mass spectrometry). WT plants without the proMBD7::MBD7-
4xMYC transgene served as controls. A total of 249 proteins were co-precipitated
with MBD7-4xMYC in transgenic plants, but only 79 of the 249 were absent in con-
trol samples. Of the 79 proteins, three were of particular interest: IDM1, IDM2 and
IDM3 (Table 2.1). These three genes are known to be involved in the DNA demethy-
lation pathway [7, 31] . We also isolated mutants of these three genes from the same
genetic screen of mbd7-1 [31] , indicating that they also function in anti-silencing.
Yeast two-hybrid (Y2H) assays were used to determine whether MBD7 interacts
directly with IDM1, IDM2, and IDM3. Full-length MBD7 was transferred into yeast
together with these genes to test their interactions. Yeast cells expressing MBD7
and IDM3 grew on both minus-three media (media lacking leucine, tryptophan, and
Histidine) and minus-four media (media lacking leucine, tryptophan, histidine and
adenine) (Fig.2.39), suggesting a strong interaction between MBD7 and IDM3. MBD7
and IDM2 co-transferred yeast cells grew on minus-three media but not on minus-
four media (Fig.2.39), indicating moderate binding between MBD7 and IDM2. MBD7
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was not observed to interact with IDM1 in the Y2H assay (data not shown). The
interaction between MBD7 and IDM2 or IDM3 was confirmed in a split luciferase
transient expression assay in protoplasts. Results in protoplasts were consistent with
those of the Y2H assays. IDM3 and MBD7 have a strong interaction, while IDM2
and MBD7 have a weaker interaction (Fig.2.40).
MBD7 contains four functional domains, including three MBD domains and one
C-terminal domain (StkC) (Fig.2.41) [28, 29]. Y2H assay indicated that both IDM2
and IDM3 bind to the StkC domain of MBD7 rather than to the three MBD do-
mains (Fig.2.42 and 2.43). To test whether StkC, the protein-interacting domain,
is important for the anti-silencing function of MBD7, we separately transferred the
native promoter-driven full MBD7 cDNA (proMBD7::cMBD7-4xMYC ) and native
promoter-driven cDNA of the three MBD domains (proMBD7::c3MBD-4xMYC ) into
mbd7-1. The three MBD domains (lacking the StkC domain) could not rescue the
root phenotype of mbd7-1 (Fig.2.44), indicating that the StkC domain is required for
the anti-silencing function of MBD7, at least at the 35S::SUC2 transgene locus.
2.3.8 MBD7 affects a subset of genomic regions targeted by active DNA
demethylation
IDM1 and IDM2 have been shown to be required for preventing the hyperme-
thylation of hundreds of genomic regions that are a subset of the targets of active
demethylation by ROS1, DML2 and DML3 [7, 31]. We previously determined the
methylomes of the idm1-1, idm2-1 and rdd (ros1dml2dml3) mutants, which were T-
DNA insertion mutants in the Col-0 background. The 35S::SUC2 genetic background
has a big impact on the DNA methylome (data not shown). In order to compare the
effect of mbd7 with those of idm1, idm2 and rdd mutations on the DNA methylome,
we sequenced the DNA methylome of the mbd7-2 mutant, which is a T-DNA inser-
tion allele in the Col-0 background. To analyze the overlaps of hyper-DMRs between
the mutants, we generated lists of hyper-DMRs regardless of CG, CHG and CHH
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sequence contexts using a method that we previously employed [7, 31]. The anal-
ysis found 2094 DMRs with increased DNA methylation (hyper-DMRs) in mbd7-2.
Approximately half (1049) of the hyper-DMRs in mbd7-2 overlaps with the hyper-
DMRs in rdd mutants, and 33% (690) overlaps with the hyper-DMRs in the ros1-4
mutant. Of the hyper-DMRs in idm1-1 and idm2-1 mutants, 30.3% (661) and 29.2%
(608), respectively, are also hypermethylated in mbd7-2. Several examples shared
and not shared hyper-DMRs in the mbd7-2, idm1, idm2 and rdd mutants are shown
in Fig.2.45, which also display ChIP-seq results showing MBD7 enrichment levels in
these regions.
We noticed that about half of the hyper-DMRs in idm1-1 or idm2-1 have DNA
hypermethylation at only CGs, while another half have hypermethylation in both
CG and non-CG contexts. In contrast, only about 8% (161) of the hyper-DMRs
in mbd7-2 are hypermethylated at only CGs. Out of the hyper-DMRs in idm1-1
and idm2-1 that overlap with those in mbd7-2, 83% (495) and 81% (429), respec-
tively, have hypermethylation in both CG and non-CG contexts (Fig.2.46). This
suggests that that IDM1, IDM2 and MBD7 tend to work together at regions where
both CG and non-CG hypermethylation need to be prevented. Our results suggest
that MBD7 affects only a subset of genomic regions that require IDM1 or IDM2
for demethylation. To understand how MBD7 may distinguish these regions from
others, we analyzed the CG methylation level and CG methylation density of the
different groups of hyper-DMRs. In both idm1 and idm2 mutants, the hyper-DMRs
that overlap with those in mbd7-2 have higher CG methylation density than the non-
overlapping hyper-DMRs. Simulations with randomly selected regions do not show
a significant difference (Fig.2.47). The results suggest that MBD7 functions together
with IDM1 and IDM2 preferentially at genomic regions with a high CG methylation
density, consistent with the requirement of high mCG density for MBD7 binding.
Indeed, analyses of the MBD7 ChIP-seq data showed that MBD7 is more enriched at
the overlapping than the non-overlapping hyper-DMRs. No significant difference was
found using the control ChIP-seq data from WT plants (Fig.2.48).
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2.3.9 MBD7 promotes the expression of endogenous loci
Although TEs represented most of the DMRs and MBD7-binding loci, under
normal conditions TE transcripts are not abundant; therefore, detecting enhanced
silencing of TEs in the mbd7 mutant is difficult. Expression of repeats, like ONSEN
and TSI, can be induced by prolonged heat treatment [35]. Heat-induced expression
of repeats enabled us to detect changes in TE transcripts between the WT and mbd7-
1. After 36 h at 37◦C, RNA from the WT and mbd7 mutants was extracted and
subjected to RT-qPCR. In two alleles of MBD7, mbd7-1 and mbd7-2, heat-induced
expression of ONSEN and TSI was lower compared to that in the WT (Fig.2.49 and
2.50). Because the primers used for ONSEN and TSI detected transcripts from all
copies of ONSEN or TSI, we designed two pairs of primers for specific detection of
transcripts of AT1G21945 and AT1G58140, which are two copies of ONSEN genes.
In both mbd7-1 and mbd7-2, heat-induced expression of AT1G21945 and AT1G58140
was compromised, which is consistent with the results obtained for all ONSEN copies
(Fig.2.49). HSP70 was used as a control to show effective heat treatment (Fig.2.50).
ChIP-seq of MBD7-4xMYC revealed an enriched MBD7 signal at ONSEN and TSI
regions, and increased DNA methylation at ONSEN and TSI was observed in mbd7-1
(Fig.2.51and 2.52). The results suggest that physical binding of MBD7 at these loci
may antagonize TE silencing by preventing DNA hypermethylation.
2.4 Discussion
In this study, we discovered a new cellular anti-silencing factor, MBD7, required
for stopping DNA methylation spread or avoiding hypermethylation to prevent tran-
scriptional gene silencing. DNA methylation is a conserved epigenetic mark for the
silencing of TEs and other invasive elements [36–38]. Many plant and animal genomes
are occupied mainly by transposable elements (TEs), such that the genes are islands
in the sea of TEs [39–41]. When the TEs are silenced by DNA methylation, the
methylation may spread and the spread would cause silencing of nearby genes [40,41].
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In order for the many TE proximal genes to be properly expressed during develop-
ment or in response to environment changes, mechanisms must exist to prevent DNA
methylation spread from TEs. Active DNA demethylation is one such mechanism.
For example, the EPF2 gene that controls the size of stomatal stem cell population
is close to a methylated TE in Arabidopsis, and active DNA demethylation is re-
quired for preventing methylation spread from the TE and therefore for preventing
transcriptional silencing of EPF2 [42]. In the DNA demethylase ros1 mutants, EPF2
is silenced by DNA methylation that is spread from the proximal TE, resulting in
an over-production of stomatal lineage cells [42]. Many imprinted genes in plants
require the DNA demethylase DME for DNA demethylation and expression in the
endosperm because the imprinted genes evolved to have TEs in or near their regu-
latory sequences [43, 44]. Active DNA demethylation is also necessary for pruning
the DNA methylation landscape of many TEs and is thus important for preventing
over-silencing of TEs [45]. In addition, transgenes are often subjected to transcrip-
tional as well as posttranscriptional silencing in plants. It has long been known that
DNA methylation can cause transcriptional silencing of transgenes in plants [46]. It
is important to understand how transcriptional silencing of transgenes is avoided or
prevented in order to keep transgenic traits stable in the agricultural biotechnology
industry.
The key enzymes for active DNA demethylation have been identified in recent
years. In mammals, active DNA demethylation starts from oxidation of 5mC by
TETs, followed by the DNA glycosylase TDG [47], while in plants, active DNA
demethylation is initiated by the ROS1/DME family of 5mC DNA glycosylases [1].
The mechanisms for targeting the active DNA demethylation enzymes to specific
genomic loci are poorly understood. In plants, the histone acetyltransferase IDM1
is required for targeting ROS1 to a subset of genomic loci for demethylation [7].
Although it is not known how H3K18 and H3K23 acetylation marks created by IDM1
affect ROS1 targeting, such a regulation may be considered as an “acetylation switch”,
analogous to what has been proposed for the targeting of the chromatin remodeling
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complex SWR1 in yeast [48]. Like IDM1, IDM2 regulates the demethylation of a
similar subset of genomic loci targeted by the ROS1 family of demethylases [31].
IDM2 is a nuclear alpha-crystallin domain (ACD) protein that mainly affects the
H3K18 acetylation activity of IDM1. IDM2 interacts with IDM1 in vitro and in
vivo [31], and thus may be considered as a partner protein of IDM1. Interestingly,
we found in this study that IDM3, an ACD protein that is closely related to IDM2,
is also required for preventing DNA hypermethylation and gene silencing.
MBD7 is a novel MBD protein that contains three MBD domains and a C-terminal
Stkc domain [28, 29]. Consistent with its capacity to bind methylated CpGs in vitro
[19], our ChIP-seq assays found that it binds to thousands of genomic regions, and
the binding correlates with the density of methylated CG but not methylated CHG
or CHH sites. This binding is coincident with the role of MBD7 in preventing DNA
hypermethylation. Therefore, instead of reading the DNA methylation signal to cause
silencing, MBD7 interprets the DNA methylation signal to avoid DNA methylation
spread or hypermethylation to prevent silencing. Many genes have high levels of CG
methylation in their gene bodies, but this type of CG methylation does not cause
silencing [2, 49]. Our results show that MBD7 binding also requires the presence
of non-CG methylation, so it does not bind to these genes since their methylation
is exclusively mCG. It will be of interest to determine how MBD7 distinguishes CG
methylation with the presence of non-CG methylation from exclusive CG methylation.
It is possible that specific chromatin features associated with the presence of non-CG
methylation influences MBD7 binding.
MBD7 interacts directly with both IDM2 and IDM3, with the interaction with
IDM3 being stronger. Like IDM2, IDM3 also interacts with IDM1. In addition,
IDM2 and IDM3 interact with each other. Our IP-LC-MS results show that MBD7 is
associated with IDM1 as well as with IDM2 and IDM3 in vivo. The IP-LC-MS results
indicated that the amounts of IDM1 and IDM2 that were pulled down with MBD7
were low, compared to the amounts of IDM3 (Table 2.1). The results suggest that
while MBD7 and IDM3 may exist in a tight complex, IDM2 and IDM1 are loosely
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associated with the complex or in the complex only part of the time. In addition to
having three MBD motifs, MBD7 also contains an Stkc domain that is conserved in
plant MBD7 orthologs but is not found in other proteins. Our results show that the
Stkc domain is necessary for MBD7 function in anti-silencing in plants, consistent
with the Stkc domain being responsible for mediating the interaction of MBD7 with
IDM2 and IDM3.
Our results suggest a model in which MBD7 binds to methylated TEs and other
repeats through its MBD motifs, and uses its Stkc domain to bind to IDM3 and IDM2,
to bring IDM1 to the methylated DNA (Fig.2.53). The H3K18ac and H3K23ac marks
created by IDM1 then allow ROS1 and related DNA demethylases to be recruited
to stop methylation spread or to prevent hypermethylation by active demethylation
(Fig.2.53). Consistent with this model, H3K18ac and H3K23ac marks are reduced
in mbd7 mutant plants, as in idm1 plants at the tested loci. It is interesting that
IDM1 also contains an MBD domain that can bind methylated CG in vitro [7]. It
seems that the single MBD domain of IDM1 is not sufficient to bring IDM1 to some
of its target genomic regions, and the targeting requires MBD7 that contains mul-
tiple MBD domains. Nevertheless, the single MBD domain may help anchor IDM1
to the genomic sites once it is recruited by MBD7. MBD7 may also help recruit
histone modification enzymes other than IDM1 to help target the DNA demethy-
lases since IDM1 only affects a subset of genomic regions demethylated by ROS1 and
related DNA glycosylases. On the other hand, MBD7 affects only a subset of ge-
nomics regions subjected to active DNA demethylation, indicating also the presence
of MBD7-independent mechanisms of targeting the DNA demethylases.
2.5 Material and methods
2.5.1 Plant materials and growth conditions
All plants were Arabidopsis in Col-0 genetic background unless stated otherwise.
Wild-type (WT) plants contained three transgenes: 35S promoter-driven SUC2, dou-
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ble 35s promoter-driven HPTII, and double 35s promoter-driven NPTII. Seeds were
disinfested in 50% (vol/vol) bleach for 15 minutes and then washed five times with




medium. Plants were grown at 23C in a growth chamber with 16 h of light and 8 h of
darkness. The medium used for examining root phenotype was
1
2
MS with 2% sucrose
and 1% agar. Otherwise, 1% glucose was added to the
1
2
MS medium to avoid root
growth suppression by sucrose. mbd7-2 (CS876032) was ordered from the Arabidop-
sis Biological Resource Center (http://www.arabidopsis.org). mbd7-2 was crossed to
the WT containing the 35S::SUC2 transgene. In the F2 population, homozygous of
mbd7-2 containing 35S::SUC2 transgene was isolated and examined for root-length
phenotype.
2.5.2 Mutant screening
An EMS-mutagenized pool of plants was generated and screened for mutants with
a long-root phenotype. M2 seedlings were grown vertically on
1
2
MS plates with 2%
sucrose and 1% agar. WT plants exhibit severely suppressed root growth on this
medium, and we screened for mutants with long-root phenotype among 10-day-old
seedlings. mbd7-1 was obtained from this screening.
2.5.3 Map-based cloning
Genetic mapping was performed as described previously [32]. Briefly, a map-




2% sucrose and 1% agar, F2 plants with a long-root phenotype were selected for
genetic mapping. For rough mapping, 96 plants and 25 simple sequence length poly-
morphisms (SSLP) markers evenly distributed across five chromosomes were used
to locate the mutation. Through rough mapping, the mutation was determined to
be located between Chr.5 22800000 and Chr.5 24724000. For fine mapping with
708 additional plants and 7 SSLP markers, the mutation was narrowed to Chr. 5:
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23900000-24200000. Whole-genome sequencing of the mbd7-1 mutant was performed
to find the mutated gene.
2.5.4 Complementation experiments
To generate complementation lines, MBD7 native promoter-driven full-length
MBD7 genomic DNA was amplified and inserted into the pENTRY- D-topo vector
(Invitrogen, cat. K2400-20). Through LR recombination reaction, proMBD7::gMBD7
was inserted into the pGWB16 vector (with a 4xMYC tag at the C terminal) and into
the pGWB4 vector (with a GFP tag at the C terminal). pGWB16-proMBD7:gMBD7-
4xMYC and pGWB4-proMBD7:gMBD7:GFP were transferred into Agrobacterium
tumesfaciens GV3101, and then flowering mbd7-1 plants were subjected to flower
dip transformation. Transgenic plants were genotyped by PCR amplification of
transgenes, and transgene expression was examined by western blot using 12-day-old
seedlings. Unsegregated T3 plants were identified as homozygous complementation
lines and were used for MBD7 ChIP assay.
2.5.5 Northern blot, RT-PCR, and RT-qPCR
According to the manufacturer instructions, total RNA was extracted with Tri-
zol reagent (Ambion, 15596-026) from 12-day-old seedlings, except that heat-treated
seedlings were only 8 days old. Turbo DNase (Ambion, AM2238) was used to remove
DNA contamination from total RNA. A 10 μg quantity of total RNA was treated
with 1 μl of DNase I in a 20 μl reaction for 30 min at 37◦C; the reaction was stopped
by adding 2 μl of inactivation reagent and incubating the preparation at room tem-
perature for 5 min. For reverse transcription, 1 μg of RNA and oligo dT primers were
used to synthesize cDNA using the qScript cDNA SuperMix kit (Quanta, 95048-025).
Then, 1 μl of cDNA was used as template in each reaction for both RT-PCR and
RT-qPCR. Real-time PCR was carried out on a BIO-RAD machine with PerfeCTa
SYBR Green FastMix (Quanta, 95072-250). UBC28 was used as an internal control in
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heat treatment-related reactions; for all other reactions, either ACTIN2 or ACTIN7
was used as an internal control.
For Northern Blot assay, 10 μg of RNA was run on a 1% formaldehyde Mops
agarose gel, and the RNA was transferred to a Hybond-N+ nylon membrane (GE
Healthcare) overnight [50]. Probes were synthesized by gene-specific PCR amplifi-
cations and labeled using the PCR DIG Probe Synthesis Kit (Roche, 11636090910).
Hybridization, washing, and detection were performed following the protocol pro-
vided with the DIG-High Prime DNA Labeling and Detection Starter Kit II (Roche,
11585614910)
2.5.6 Whole-genome bisulfite sequencing
Fourteen-day-old mbd7-1 and WT seedlings were used for genomic DNA extrac-
tion. Then, bisulfite conversion, library construction, and deep sequencing were per-
formed by the Beijing Genomics Institute (BGI, in Shenzhen, China).
2.5.7 Chop-PCR
Genomic DNA was extracted from 12-day-old mbd7-1 and WT seedlings. Af-
ter RNase (invitrogen) treatment at 37◦C for 1 h, DNA was purified with pheno-
chloroform-isopropyl (Thermo, 17909) and precipitated by 2V ethanol and 1/10V
NaOAC (3 M, pH 5.2). In a 30-μl reaction, methylation-sensitive enzymes were used
to digest 500 ng of DNA for 16 h, and 2 μl was used for PCR amplification. The
HpaII used in Chop-PCR were obtained from New England Biolab (NEB) company.
2.5.8 Chromatin immune-precipitation (ChIP) assay
The ChIP assay was performed were as previously described [51]. In brief, 3 g of
14-day-old seedlings was collected, placed in 35 ml of 1% formaldehyde PBS buffer,
and then fixed by vacuum for 2 min followed by another 8 min. After glycine was
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added, samples were subjected to a vacuum for 5 min to stop the fixation. Samples
were washed three times with sterile water and then ground into powder with liquid
nitrogen. Nuclei were extracted with Honda Buffer. The nuclei solution was sonicated
to break genomic DNA into 500-bp fragments. After centrifugation, supernatants
were removed and used for immuno-precipitation. Dynabeads (Invitrogen,10003D)
were used for pre-clear and antibody binding. The antibodies were: anti-H3K9me2
(Abcam), anti-H3K18ac (Abcam, ab1191), anti-H3K23ac (Millipore, 07-355), anti-
MYC (Millipore, 05-724), and anti-Pol II (Abcam, ab5408). Precipitated DNA was
dissolved in 30 μl of nuclease-free water, and 2 μl was used for qPCR amplification.
2.5.9 ChIP-seq
proMBD7::gMBD7: 4xMYC transgenic plants were used for ChIP-seq, with WT
plants as controls. ChIP was performed according to a previously published protocol
[51]. ChIP samples were sent to the Genomics Core Facilities of the Shanghai Center
for Plant Stress Biology, SIBS, CAS (Shanghai, China) for library construction and
Illumina sequencing.
2.5.10 RNA-seq
RNA was isolated from 14-day-old seedlings of mbd7-1 and the WT, and the
method for extraction of total RNA was the same as described above. Oligo (dT)-
conjugated magnetic beads (Qiagen) were used to enrich mRNAs, and then samples
were sent to BGI, where library construction and Illumina sequencing were performed.
2.5.11 MethylC-Seq data analysis
For data analysis, low quality sequences (q<20) were trimmed using trim in
BRAT-BW [52], and clean reads were mapped to the TAIR10 genome using BRAT-
BW and allowing two mismatches. To remove potential PCR duplicates, the remove-
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dupl command of BRAT-BW was used. Differentially methylated regions (DMRs)
were identified as described previously [53] with minor modifications. The DMRs
were separately identified for each of the three contexts (CG, CHG, and CHH). For
each context, the Arabidopsis genome (TAIR10) was divided into 100-bp windows,
and the number of called Cs and Ts were compared. Windows with an absolute
methylation difference of 0.4, 0.2, and 0.1 for CG, CHG, and CHH, respectively, were
selected as candidate DMRs. Finally, windows with Benjamini-Hochberg corrected
FDR ≤ 0.01 (Fisher exact test) and at least 4 cytosines in the corresponding context
that are each covered by at least 4 reads in both mutant and wild-type were retained.
2.5.12 MBD7 ChIP-Seq Analysis
The quality of the sequencing data was checked with FastQC (http://www.bioinformatics.babrah
The paired-end reads were mapped to the unmasked TAIR10 genome of Arabidopsis
thaliana by means of bowtie2, allowing the mapping of up to 10 different genomic
sites with parameter “-k 10 –no-mixed –no-discordant -I 0 -X 1000” [54]. To remove
potential PCR duplicates, rmdup from SAMtools [55] was used. Peaks were called
with MACS2 callpeak function [56], comparing the two replicates of MBD7-Myc ChIP
samples with the two replicates of wild-type control. The genome size (-g) was set at
1.2e8, and the -keep-dup parameter was set as “all”.
Relationship between MBD7 ChIP Enrichments and mCG identity The Arabidop-
sis genome was divided into 1-kb bins with an overlap of 500 bp. The MBD7 protein
enrichment definition was similar as that of [34]. They were calculated as follows:
Enrichment = log2(8 + n ChIP) - log2(8 + n Input * N ChIP/N Input)
where n ChIP and n Input represent the number of mapped ChIP and input tags,
respectively, in the corresponding 1-kb bin. N ChIP and N Input are the sum of all
mapped tags. Eight pseudo counts were added to overcome sampling noise. The pro-
gram featureCounts [57] was used to obtain n ChIP and n Input. mCG(CHG/CHH)
density was calculated as sum of CG(CHG/CHH) methylation level in the corre-
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sponding 1kb bin and normalized to 100 bp. Only those 1-kb bins that had at least
80% CG(CHG/CHH) covered by ≥ 4 reads were used for downstream analysis.
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2.7 Figures and tables
Fig. 2.1. Isolation of the 91-1 mutant based on its long root phe-
notype. Wild-type (WT) plants with the 35S::SUC2 (sucrose trans-
porter 2 gene driven by the CaMV 35S promoter) transgene display
a short root phenotype on medium containing sucrose, while mbd7
mutant plants have long roots. The root growth of Col-0, WT, and
91-1 on glucose medium served as controls.
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Fig. 2.2. Hygromycin and kanamycin sensitivity of 91-1 mutants.
2x35S::HPTII and 2x35S::NPTII also exist in WT plants, leading
to both hygromycin and kanamycin resistance. Comparison of Col-
0, the WT, and the 91-1 mutant showed that the 91-1 mutant was
sensitive to both hygromycin and kanamycin; with growth on medium
without antibiotics served as the control. However, the kanamycin
sensitivity of 91-1 mutants was compromised by treatment with the
DNA methylation inhibitor 5 - Aza.
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Fig. 2.3. Expression level of transgenes in 91-1 mutant plants.
(A) Transcript levels of SUC2 and HPTII in 91-1 mutant plants.
Northern blot was used to determine the expression level of trans-
genes. Compared to the WT, 91-1 mutant plants had reduced levels
of SUC2 and HPTII transcripts. The level of SKP1 transcripts was
used as the loading control.
(B) Expression levels of SUC2, HPTII, and NPTII in 91-1 mutant
plants were examined using RT-qPCR.
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Fig. 2.4. Identification of the mutation in the 91-1 mutant that is
responsible for transgene silencing.
(A) Map-based cloning of 91-1. The top line is the diagram of chromo-
some 5 of Arabidopsis. The lower line is the diagram of chromosome
region containing MBD7 (AT5G59800). Positions of molecular mark-
ers used for mapping are shown below the lower line. Ratios on the
bottom of the diagram are the numbers of recombinants over the total
numbers of mapped chromosomes.
(B) Diagram showing the EMS mutation site in the mbd7-1 (91-1 )
mutant and the T-DNA insertion position in mbd7-2.
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Fig. 2.5. Genotyping of mbd7-2 containing 35S::SUC2 transgene.
The diagram shows positions of primers used in genotyping the mbd7-
2 mutant containing the 35S::SUC2 transgene. Wild-type plants were
used as controls. Full-length genomic DNA of MBD7 was amplified
withMBD7 F andMBD7 R primers. T-DNA insertion was genotyped
using Lb1 and MBD7 R. Primers of 35sF and SUC2 R were used to
amplify the 35S::SUC2 transgene.
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Fig. 2.6. Root phenotype of mbd7-2. 35S::SUC2 was introduced into
another allele of mbd7 mutant, mbd7-2 (CS876032). On a medium
containing sucrose, mbd7-2 has the same long root phenotype as
mbd7-1.
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Fig. 2.7. Functional complementation of the mbd7-1 mutant.
(A) Complementation of the mbd7-1 mutant restored the short root
phenotype. Expression of native promoter driven genomic DNA of
MBD7 could rescue the root phenotype of mbd7-1 mutants.
(B) Restored expression level of SUC2 and HPTII in MBD7-
4xMYC/mbd7-1 transgenic plants. Actin2 expression level is shown
as a control.
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Fig. 2.8. Determination of Pol II occupancy at 35S promoters.
(A) Diagram of the 35S::SUC2 transgene and labeling of examined
regions in the ChIP assay.
(B) Pol II occupancy at the transgene promoter was tested in the
wild type and mbd7-1. A ChIP assay used 12-day-old seedlings and
antibody against Pol II. Actin2 was used as the control region.
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Fig. 2.9. Determination of H3K9me2 level at the 35S promoter.
(A) Diagram of the 35S::SUC2 transgene, and labeling of examined
regions in the ChIP assay.
(B) H3K9me2 level at the 35S promoter and control region. ChIP
was performed in wild-type and mbd7-1 plants with anti-H3K9me2
antibody. Actin2 was used as the control region.
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Fig. 2.10. Determination of H3K18ac level at the 35S promoter.
(A) Diagram of the 35S::SUC2 transgene, and labeling of examined
regions in the ChIP assay.
(B) H3K18ac level at the 35S promoter and control region. ChIP was
performed in wild-type, mbd7-1, and idm1-9 plants. Actin7 was used
as the control region.
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Fig. 2.11. Determination of H3K23ac level at the 35S promoter.
(A) Diagram of the 35S::SUC2 transgene, and labeling of examined
regions in ChIP assay.
(B) H3K23ac level was examined at the 35S promoter and control
region. ChIP assay was performed in wild-type, mbd7-1, and idm1-9
plants.
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Fig. 2.12. DNA methylation status of the 35S::SUC2 transgene in the
wild type and mbd7-1. Bisulfite sequencing results are displayed as a
screenshot of IGB tracks. The upper lane indicates the methylation
status in the WT, which served as the control. The lower lane indi-
cates the methylation status in mbd7-1. Each orange bar represents
a methyl cytosine, and the height of the bar indicates the methyla-
tion level of the single cytosine. The 35S::SUC2 transgene diagram
is shown above the screenshot.
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Fig. 2.13. Hyper- and hypo-DMRs (differently methylated regions)
in mbd7-1. Whole-genome bisulfide sequencing was performed using
12-day-old seedlings. With wild-type plants as controls, hyper- and
hypo methylated regions in mbd7-1 were identified in CG, CHG, and
CHH contexts.
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Fig. 2.14. Determination of DNA hypermethylated loci in mbd7-1
using Chop-PCR. Ten loci were selected to validate whole-genome
bisulfite sequencing results. Chop-PCR was performed with two bio-
logical replicates. Methylation-sensitive restriction enzymes were used
to digest genomic DNA of the wild type and mbd7-1 mutants.
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Fig. 2.15. Examples of hypermethylated regions in mbd7-1. The
methylation status of total mC, mCG, mCHG, and mCHH in the
wild type and mbd7-1 is shown. For most DMRs, either the amount
or level of mCHH and mCHG were increased in mbd7-1, as indicated
in the two regions to the left. For some regions, the mCG level also
changed, as shown in the third screenshot.
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Fig. 2.16. Composition of hyper-DMRs in mbd7-1. Compositions of
hypermethylated regions in the mbd7-1 mutant were analyzed based
on CG, CHG, and CHH contexts.
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Fig. 2.17. Average methylation levels in hyper-DMR-associated TE
bodies and flanking 2-kb regions. Each TE was aligned from start to
end and divided into 20 equal bins. Upstream and downstream 2-kb
regions were each also divided into 20 equal bins. Methylation level
was calculated for each of the 60 bins across all of the corresponding
regions and plotted. Only cytosines with > four-fold coverage were
used for this analysis.
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Fig. 2.18. Compositions of total TEs and TEs with hyper mCHH in
mbd7-1. TE categories are labeled with different colors.
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Fig. 2.19. Average methylation level of hyper-DMR-associated TEs
with different lengths. DMR associated-TEs were classified by length.
The range of lengths is indicated above the figure.
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Fig. 2.20. Chromosomal distribution of hyper-DMRs in mbd7-1.
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Fig. 2.21. Position preference of hyper-DMR-associated TEs in mbd7.
Number of total TEs and mbd7-1 hyper-DMR-associated TEs was
calculated in every 500-kb window of the genome. The distribution of
TE number/500 kb along five chromosomes is shown in the first and
second lanes. The ratios of hypermethylated TEs to total TEs per
500 kb were calculated and displayed as in the bottom figure. The
trend of hypermethylated TE ratio is represented by the black dashed
line.
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Fig. 2.22. Recombinant MBD7 protein expression in MBD7-
4xMYC/mbd7-1. Western blot was used to detect recombinant MBD7
protein expression in transgenic plants. WT was used as the control.
Positions of molecular mass markers are on the left.
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Fig. 2.23. Correlation of MBD7 enrichment with DNA methylation
level. The top 1% of MBD7-enriched regions was selected for analysis.
For each region, MBD7 enrichment was represented by color from
light yellow (lowest) to red (highest). Windows were ranked by mCG,
mCHG, and mCHH methylation levels.
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Fig. 2.24. Correlation of MBD7 enrichment with DNA methylation
density. The top 1% of MBD7-enriched regions was selected for anal-
ysis. For each region, MBD7 enrichment was represented by color
from light yellow to red. Windows were ranked by mCG, mCHG, and
mCHH methylation density.
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Fig. 2.25. Genome-wide relationship between MBD7 enrichment and
DNA methylation densities. Genomic 1-kb bins were used in this
analysis. ChIP-seq of the wild type served as the control. All 1-kb
bins were ranked by mCG, mCHG, or mCHH methylation density.
The blue dashed line indicates the DNA methylation density, and red
line indicates MBD7 enrichment.
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Fig. 2.26. Screenshots showing endogenous MBD7-binding targets.
Total DNA methylation of the wild type is labeled by orange bars in
the first row, and CG methylation of the wild type is labeled by yellow
bars in the second row. The 3rd and 4th rows are MBD7 enrichment
in WT and MBD7-4xMYC transgenic plants, respectively. MBD7
enrichment is labeled by blue bars. Gene or TE annotations are below
the screenshot.
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Fig. 2.27. Composition of endogenous MBD7 binding targets based
on analysis of 2452 peaks of ChIP-seq signals.
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Fig. 2.28. Comparison of mCG methylation density between genes
and TEs. Total 1-kb gene windows and 1-kb TE windows were used
in this analysis. Methylation density of gene windows is indicated by
purple, and methylation density of TE windows is indicated by green.
Gene windows were 1-kb windows that had at least a 500-bp overlap
with genes but not with TEs. TE windows were 1-kb windows that
had at least a 500-bp overlap with TEs.
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Fig. 2.29. Comparison of MBD7 enrichment between 1-kb gene and
TE windows with similar mCG methylation densities. One-kb gene
and TE windows with 1.8-2.2 mCG methylation density were used.
mCG methylation densities of gene windows and TE windows are
displayed on the left of the figure, and their corresponding MBD7
enrichment is shown on the right of the figure.
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Fig. 2.30. Comparison of MBD7 enrichment between 1-kb gene and
TE windows with similar mCGmethylation density. This analysis was
similar to that shown in Figure 28, except that three mCG methyla-
tion density ranges were selected: 0.8-1.0, 1.0-1.4, and 1.4-1.8. Gene
and TE windows within the same range were used to compare their
MBD7 enrichment. For each mCG methylation density range, com-
parable mCG methylation density between gene and TE windows is
shown on the left, and their MBD7 enrichment is shown on the right.
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Fig. 2.31. Comparison of MBD7 enrichment between windows with
and without non-CG methylation. One-kb windows with 1.8-2.2 mCG
methylation density were used. Windows were sorted by absence (type
I) or presence (type II) of non-CG methylation, including mCHG and
mCHH. mCG methylation densities of type I and type II windows are
displayed on the left, and their MBD7 enrichment is shown on the
right. The cutoff of methylation level for mCHG and mCHH is 5%.
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Fig. 2.32. Comparison of MBD7 enrichment between windows with
and without non-CG methylation. This analysis is similar to that of
Figure 31, except that three mCG methylation density ranges were
used: the 1-kb windows had methylation densities of 0.8-1.0, 1.0-
1.4, and 1.4-1.8. 1.8-2.2. Windows were classified by absence (type
I) or presence (type II) of non-CG methylation. mCG methylation
densities of type I and type II windows are displayed on the left, and
their MBD7 enrichment is shown on the right.
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Fig. 2.33. Correlation of MBD7 enrichment with DNA hypermethy-
lation in mbd7-1 mutant plants. For each 50-kb genomic window,
MBD7 enrichment and the number of hypermethylated cytosines [hy-
per differentially methylated cytosines (hyper-DMCs)] inmbd7-1 were
calculated. Hyper-DMC was defined as cytosines that showed a 1.5X
increase in methylation level in mbd7-1 compared to WT.
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Fig. 2.34. Correlation of MBD7 enrichment with hyper mCG, mCHG,
and mCHH in mbd7-1 mutant plants. Hypermethylated cytosines in
mbd7-1 were classified by mCG, mCHG, and mCHH contexts. For
each 50-kb genomic window, MBD7 enrichment and the numbers of
hyper mCG, mCHG, and mCHH were calculated.
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Fig. 2.35. The effect of MBD7 binding on DNA methylation. The av-
erage methylation levels of 2452 peaks were calculated. The methy-
lation levels of mCG, mCHG, mCHH, and total mC are displayed
separately. Random regions were selected through computational sim-
ulation based on the lengths of the 2452 peaks. The purple line in-
dicates the methylation level in mbd7-1, and the green line indicates
the methylation level in the wild type.
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Fig. 2.36. MBD7 binding at the 35S transgene promoter. Diagram
for 35S::SUC2 transgene is on the top. Upper two lanes are DNA
methylation status of 35S::SUC2 transgene in wild type and mbd7-1
respectively. MBD7 enrichment at the transgene is shown in the lower
two lanes.
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Fig. 2.37. Examination of MBD7 enrichment at transgene promoter
using individual locus ChIP assay. Examined regions are as indicated
above the figure. Promoter of ACTIN7 was used as the control.
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Fig. 2.38. Screenshots showing that DNA methylation level is in-
creased in MBD7-binding regions. In the wild type and mbd7-1,
methylation levels of total mC, mCG, mCHG, and mCHH are shown
separately. The last two rows indicate MBD7 enrichment in the WT
and MBD7-4xMYC transgenic plants. MBD7 enrichment is labeled
by blue bars. Gene or TE annotations are below the screenshot.
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Fig. 2.39. MBD7 physically interacts with IDM2 and IDM3. IDM2
and IDM3 are two closely related alpha-crystallin domain proteins
that also function in anti-silencing. Protein interactions were tested
using the yeast two-hybrid assay. Yeast growth on media without Leu
(leucine), Trp (tryptophan), and His (Histidine) indicates an interac-
tion between two proteins.
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Fig. 2.40. Interaction of MBD7 with IDM2 and IDM3 using split lu-
ciferase transient expression assays. Tested proteins were transiently
expressed in Arabidopsis protoplasts. The co-transferred GUS trans-
gene was used to standardize protoplast transfer efficiency. Proto-
plasts expressing the tested protein and irrelevant proteins including
AHGI (ABA-hypersensitive germination 1) and PYL13 (PYR1-like
protein 13) served as negative controls.
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Fig. 2.41. Diagram showing structures of full MBD7 and truncated
MBD7 used in Y2H assay. The full MBD7 contains three MBD do-
mains and one STKC domain, as shown on the first row. The trun-
cated MBD7 protein labeled 3MBD in the second row contains three
MBD domains (1-232 aa). The truncated MBD7 protein labeled as
STKC in the bottom row contains only the STKC domain (232-306
aa).
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Fig. 2.42. Y2H assay testing interactions between IDM2 and trun-
cated MBD7 proteins. BD-fused 3MBD, BD-fused STKC, and AD-
fused IDM2 were used in this Y2H assay. Media lacking Leu, Trp, and
His were used to detect moderate protein interaction. Media lacking
Leu, Trp, His, and Ade (adenine) were used to detect strong protein
interaction.
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Fig. 2.43. Y2H assay testing protein interactions between IDM3 and
truncated MBD7 proteins. BD-fused 3MBD, BD-fused STKC, and
AD-fused IDM3 were used in this Y2H assay. Media lacking Leu,
Trp, and His were used to detect moderate protein interaction. Media
lacking Leu, Trp, His, and Ade were used to detect strong protein
interaction.
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Fig. 2.44. Complementation of the mbd7-1 mutant with a trun-
cated MBD7 construct. Native promoter-driven full MBD7 CDS
(proMBD7::cMBD7-4xMYC ) and native promoter-driven 3MBD
CDS (proMBD7::c3MBD-4xMYC ) were transferred to mbd7-1. Root
phenotypes of the two transgenic lines were tested on a sucrose-
containing medium.
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Fig. 2.45. Three examples of shared DMRs are shown in the first
three (from left to right) dashed boxes. The last three dashed boxes
show examples of hyper-DMRs that are independent of MBD7.
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Fig. 2.46. Within each DMR, hyper-methylated cytosines are classi-
fied into two types, hyper-mCG and hyper-non-mCG.
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Fig. 2.47. Simulation with randomly selected regions was shown on
the right for comparison. Mann-Whitney test was performed for sta-
tistical analyses. P-values < 0.01 indicate statistical significance
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Fig. 2.48. Simulation with randomly selected regions was shown on
the right for comparison. Mann-Whitney test was performed for sta-
tistical analyses. P-values < 0.01 indicate statistical significance.
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Fig. 2.49. Examination of heat-induced expression of ONSEN genes
in mbd7 mutants. Expression was tested in both mbd7-1 and mbd7-2
mutants, with WT and Col-0 as controls. Eight-day-old plants were
treated at 37◦C for 36 h. The gene expression levels in mbd7-1 and
in mbd7-2 are relative to those in the WT and Col-0, respectively.
Primers used to detect ONSEN could amplify cDNA from multiple
copies of ONSEN. Primers for AT1G58140 and AT1G21945 were de-
signed to specifically amplify only one copy of the ONSEN gene.
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Fig. 2.50. Examination of heat-induced expression of TSI genes in
mbd7 mutants. Heat induction of HSP70 served as a control. Eight-
day-old plants were treated at 37◦C for 36 h. The gene expression
levels in mbd7-1 and in mbd7-2 are relative to those in the WT and
Col-0, respectively. The primers used to detect TSI could amplify
cDNA from multiple copies of TSI.
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Fig. 2.51. Methylation status and MBD7 enrichment of the ONSEN
gene. AT1G21945, one of the ONSEN genes, is displayed as an exam-
ple. The first eight lanes show the methylation status of AT1G21945
in both the WT andmbd7-1. Total mC, mCG, mCHG, and mCHH are
indicated. The last two lanes show MBD7 enrichment at AT1G21945.
AT1G21945 is labeled with a black arrow below the screenshot.
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Fig. 2.52. Methylation status and MBD7 enrichment of the TSI gene.
AT1G38360, one of the TSI genes, is displayed as an example. The
first eight lanes show the methylation status of AT1G38360 in both
the WT and mbd7-1. Total mC, mCG, mCHG, and mCHH are dis-
played. The last two lanes show MBD7 enrichment at AT1G38360.
AT1G38360 is labeled with a black arrow below the screenshot. The
methylation status of the framed region (Chr. 1: 14437062-14438062)
is shown separately.
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3. IDENTIFICATION OF A MOLECULAR REGULATOR
INVOLVED IN THE ACTIVE DNA DEMETHYLATION
PATHWAY BASED ON GENETIC SCREENING IN
ARABIDOPSIS
3.1 Abstract
DNA methylation is an important epigenetic mark in diverse biological processes.
DNA methylation status can be dynamically controlled by methylation and active
demethylation processes. In plants, active DNA demethylation relies on a base exci-
sion repair pathway. Recently, a subfamily of DNA glycosylases has been identified
as DNA demethylation enzymes. However, the mechanism by which demethylation is
targeted to specific loci is poorly understood. To date, the only identified regulatory
component in the active DNA demethylation pathway is ROS3 (REPRESSOR OF
SILENCING 3), a small RNA-binding protein. ROS3 is colocalized with ROS1 (RE-
PRESSOR OF SILENCING 1) and is capable of binding single-stranded RNA. The
current working model is that ROS3 is involved in targeting demethylase enzymes to
specific loci through its RNA-binding activity. Here, we describe an enhancer mutant
screen in the ros3 background and propose to characterize a mutant, rte1 (ros three
enhancer 1), from the screen in order to identify a novel component involved in the
regulation of active DNA demethylation.
3.2 Introduction
Active DNA demethylation is critical for many plant processes such as gene im-
printing, preventing the spread of DNA methylation from repetitive sequences to
neighboring genes, and maintaining a proper dynamic state of transposons [1].
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In plants, researchers have identified a family of DNA glycosylase/lyases, including
ROS1, DME, and DMLs, whose enzymatic activities result in the replacement of a
methylated cytosine with an unmethylated cytosine [2–4]. A single-stranded RNA-
binding protein, ROS3, has been identified and to date is the only regulatory factor
known to be involved in the active DNA demethylation pathway in plants [5].
In mammals, almost all components identified in active DNA demethylation are
enzymes that can be classified into two categories. Enzymes in one category have
methylcytosine modification activities, and these include AID (activation-induced
deaminase) 127 with deaminase activity and TET1 with hydroxylase activity. En-
zymes in the second category are related to the base excision repair (BER) path-
way, and these include TDG (thymine-DNA glycosylase) and MBD4 (methylcytosine-
binding protein), both of which have glycosylase activity [3,6–9]. In addition, recent
studies showed that an ELP3-containing elongator complex may play an indirect role
in active DNA demethylation [10].
Although enzymes functioning in active DNA demethylation have been identified
and studied, the mechanism by which demethylation is targeted to specific loci re-
mains unclear in both animals and in plants. We hypothesize that plants contain reg-
ulatory factors that work together with ROS3 or function in a parallel pathway with
ROS3 to direct demethylases to specific loci. Therefore, research with the Arabidop-
sis model system may increase our understanding of how active DNA demethylation
occurs in plants and may also provide clues concerning the regulatory mechanisms of
active DNA demethylation in mammals.
In our mutant screening system, a transgene was introduced into C24 ecotype
plants of Arabidopsis. The transgene consists of the firefly luciferase reporter (LUC)
under control of the ABA-, drought-, salt-, and cold stress-responsive RD29A pro-
moter [2]. Expression of the proRD29A-LUC transgene in our transgenic Arabidop-
sis line (renamed C24-luc) has been very stable for many generations over the last
17 years. This system has been used to screen for mutants with higher or lower
expression of the proRD29A-LUC transgene. Many novel components have been
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identified from mutants with an enhanced expression of the proRD29A-LUC trans-
gene, but only two mutants have been identified so far with a repressed expression
of proRD29A-LUC. The two mutants with a repressed expression of proRD29A-LUC
are ros1 and ros3 [2,5]. In ros1 and ros3 mutants, the transgene is silenced because
of the hypermethylation of the transgenic RD29A promoter. To identify new com-
ponents involved in the DNA demethylation pathway, we performed a genetic screen
for the ros3 enhancer mutants. We found that after many generations of inbreeding,
the ros3 mutant in C24-luc shows abnormal bioluminescence in mature plants but
not in seedlings. Therefore, 10-day-old seedlings could be used to screen for ros3
enhancer mutants. In this study, rte1 (ros three enhancer mutant 1) was identified
and characterized.
3.3 Results
3.3.1 Isolation of ros3 enhancer mutants
To obtain ros3 enhancer mutants, ros3 seeds were mutagenized with the chem-
ical mutagen ethyl methanesulfonate (EMS). The M2 population was used for en-
hancer mutant screens. Expression of the transgene proRD29A:: LUC in 10-day-old
seedlings of ros3 is induced by cold treatment (Fig.3.1 A). We screened for mutants
in which the stress-induced luminescence signal was weaker than in the ros3 mutant.
The phenotype of one enhancer mutant, referred to as rte1, was confirmed (Fig.3.1
A). After a 24-h cold treatment, the C24-luc wild type and ros3 mutants displayed
strong luminescence signals, suggesting that the proRD29A-LUC transgene was well
induced (Fig.3.1A). The luminescence signal, however, was completely repressed in
the rte1 mutant and in ros1-1, which served as a positive control (Fig.3.1A). When we
treated 3-week-old seedlings with both cold and salt stress (300 mM NaCl solution)
for 6 h, similar luminescence phenotypes were observed (Fig.3.1B). In mature leaves,
LUC was not strongly induced by cold or salt treatment in ros3, but the luminescence
signal was weaker in rte1 than in ros3 (Fig.3.1C).
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Transcript levels of proRD29A:: LUC were assessed by real-time PCR. The results
were consistent with the luminescence phenotypes that the LUC transgene was well
induced in C24-luc and ros3 but not in ros1-1 or rte1 by cold treatment (Fig.3.2A).
Because the transgene driven by the RD29A promoter was repressed, we tested the ex-
pression of the endogenous RD29A gene. Like the transgene, the endogenous RD29A
gene was not well induced in rte1 relative to C24-luc and ros3, but its transcript level
was higher in rte1 than in ros1 (Fig.3.2B). COR15A was well induced in all tested
plants by cold treatment (Fig.3.2C), indicating that the cold induction was effective
and also suggesting that the repressed expression of the transgene or endogenous gene
in rte1 and ros1 was not due to abolishment of the stress signaling pathway.
Another transgene, the 35S promoter- driven NPTII transgene, was also in our
screening system. The C24-luc WT has a kanamycin-tolerant phenotype, while ros3
has moderate kanamycin sensitivity (Fig.3.3A). rte1 has stronger kanamycin sensi-
tivity than ros3, suggesting that NPTII is more repressed in rte1 than in ros3. This
inference was supported by assessment of the expression level of NPTII (Fig.3.3B).
3.3.2 rte1 is a DNA hypermethylated mutant
Because rte1 has a stronger transgene and endogenous gene silencing phenotype
then ros3, we wanted to determine whether the DNA methylation phenotype is en-
hanced in rte1 relative to ros3. Four Chop-PCR markers were used to check the
methylation status of rte1. Two markers were used to detect loci in transgenic and
endogenous RD29A promoters, and the other two markers are known to be ros1
endogenous DNA hypermethylation targets. In Chop-PCR, methylation-sensitive en-
zymes were used to digest genomic DNA before PCR amplification was performed
with primers that covered the digested sites. The results can be analyzed by compar-
ing the intensities of the amplified PCR products: a higher PCR product intensity
indicates a higher methylation level of the genomic DNA. C24-luc and ros3 served
as negative controls, and ros1-1 served as a positive control. The results show that
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the DNA methylation level at transgenic, endogenous RD29A promoter loci is higher
in rte1 than in ros3 (Fig.3.4). At AT4G18650 promoter and Pm36 LOCUS, rte1
showed a little DNA hypermethylation phenotype (Fig.3.4).
Chop-PCR could only check the methylation level of specific cytosines. To confirm
the hypermethylation level of the whole RD29A promoter region, we performed bisul-
fite sequencing of the transgenic RD29A promoter region. Bisulfite sequencing is used
to determine the methylation level at specific regions by treating genomic DNA with
sodium bisulfite. The bisulfite treatment can convert unmethylated cytosine to uracil
(C to U), while leaving 5-methylcytosine unaffected. When a PCR reaction is carried
out using the converted DNA as template, adenine (A) instead of guanine (G) will be
paired with uracil (U). Therefore, unmethylated cytosine will convert to thymidine (C
to T), and methylated cytosine (mC) will remain cytosine (Fig.3.5A). The bisulfite
sequencing results showed that, compared to the ros3 mutant, the rte1 mutant is
hypermethylated in all three contexts (CG, CHG, and CHH) (Fig.3.5B). The C24-luc
and ros3 mutants were used as negative controls, while the ros1-1 mutant was used
as a positive control.
3.3.3 Isolation of the rte1 single mutant
The rte1 mutant was screened from mutant pools generated in the ros3 mutant
background. The rte1 mutant is actually a double mutant with both the rte1 mu-
tation and the ros3 mutation. To facilitate further research on the functions of the
enhancer gene, we isolated the single enhancer mutant (hereafter referred to as the
rte1 single mutant).
The rte1 mutant was back crossed to C24-luc, and the F2 population was used
to screen for the rte1 single mutant. F2 seeds were plated on MS medium and
grown for 12 days. After a 24-h cold treatment, F2 plants were imaged with a CCD
camera. Seedlings with a lower luminescence signal than C24-luc were selected and
transferred to soil. One week later, genomic DNA was extracted from each selected
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plant, and genotyping was carried out to test for the presence of the ros3 mutation.
Plants without the ros3 mutation but with a low luminescence signal were isolated
as the single mutants, and their seeds were collected. Two individual lines of the
single mutant were isolated, and their seeds were collected separately. Their low
luminescence signal phenotype was confirmed in mature leaves (Fig.3.6A) and was
reconfirmed in their progeny (Fig.3.6B). The luminescence phenotype is stronger in
rte1/ros3 than in either ros3 or rte1 single mutants. The additive effect indicates
that RTE1 may work independently or in parallel with ROS3. We measured the
kanamycin resistance of these two single mutants. The rte1 single mutant #12 was
very sensitive to kanamycin (Fig.3.7), while the rte1 single mutant #19 was less
sensitive (data not shown).
3.3.4 The methylome of the rte1 single mutant
Based on its kanamycin phenotype, rte1 single mutant #12 was selected to fur-
ther characterize the function of the RTE1 gene. Chop-PCR marker in endogenous
RD29A promoter was used to check the methylation status of the rte1 single mu-
tant #12. Compared to C24-luc plants, rte1 single mutant #12 showed a hyper-
methylation phenotype (Fig.3.8A). To further characterize the influence of RTE1 on
DNA methylation, we performed whole-genome bisulfite sequencing using 12-day-old
seedlings of the rte1 single mutant #12. Consistent with Chop-PCR results, the
RD29A promoter region in rte1 single mutant #12 is hypermethylated (Fig.3.8B).
By comparison with C24-luc bisulfite sequencing results, we identified 498 dif-
ferentially methylated regions (DMRs) in the rte1 single mutant #12. Most DMRs
are hypermethylated regions (Fig.3.9A), suggesting that RTE1 functions in DNA
demethylation. . The composition of hypermethylated DMRs indicated that RTE1
does not have preference to TE, gene, or intergenic regions (Fig.3.9B). Four regions
were selected to illustrate the endogenous hypermethylated regions of rte1 single
mutant #12 (Fig.3.10).
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3.3.5 Genetic mapping of rte1
Genetic mapping was used to roughly locate the rte1 mutation. For genetic map-
ping, the rte1 mutant was crossed to the wild type of the Columbia ecotype (Col-0)
without the proRD29A-LUC transgene. The F2 population was screened for the
enhancer mutant phenotype based on luminescence imaging and PCR genotyping
for the presence of proRD29A-LUC. Plants with the proRD29A-LUC but without
cold-induced LUC expression were selected as the mapping population for further
experiments.
Col-0 and C24 are two ecotypes of Arabidopsis, and SSLP (simple sequence length
polymorphism) markers can be used to distinguish the two types of alleles in the
F2 mapping population. The recombination frequency (RF) can reflect the genetic
distance between two genes. The RF of unlinked genes is roughly 50%. Linked
genes cannot segregate independently during germ cell meiosis so that their RF is
<50%. In our case, the loci close to the enhancer mutation should show linkage
with the phenotype. Twenty SSLP markers, which are evenly distributed in the five
Arabidopsis chromosomes, were selected and examined in the mapping population.
According to the mapping table, 6 Mb to 8 Mb of Chromosome 4 showed linkage to
the phenotype of the rte1 mutant (Table 3.1).
3.4 Discussion
The C24-luc system is an important genetic screening system. The first identified
anti-silencing factor, ROS1, was obtained with this system [2]. The other important
anti-silencing factor obtained with this system was ROS3 [5]. To date, these are the
only anti-silencing factors screened from this system. Although obtaining additional
anti-silencing factors with this system is difficult, in the current study we used the
C24-luc system and ros3 enhancer screening to identify another factor involved in
anti-silencing, RTE1. Genetic mapping was performed, and 6 Mb to 8 Mb of Chro-
mosome 4 showed linkage to the phenotype of the rte1 mutant. For unknown reasons,
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the stress-induced transgene expression is not stable, so that the luminescence phe-
notype is not fully linked with the mutation in the rte1 mutant (data not shown).
As a result, we could not use genetic mapping to better define the region containing
the rte1 mutation.
Although the gene responsible for the anti-silencing phenotype of the rte1 mutant
remains unknown, the anti-silencing role of RTE1 was supported and confirmed by
the analysis of the rte1 mutant and rte1 single mutants. In the rte1 mutant, both
the transgene and endogenous gene driven by the RD29A promoter were silenced
because of DNA hypermethylation at the RD29A promoter region (Fig.3.2). In rte1
single mutants, the luciferase transgene was silenced (Fig.3.6), and hundreds of DNA
hypermethylated regions were identified through whole-genome bisulfide sequencing
(Fig.3.9). To exclude the possibility that RTE1 is a known gene, we sequenced all
known anti-silencing genes but found no homozygous mutation (data not shown),
indicating that RTE1 is a new component involved in anti-silencing and in prevent-
ing DNA hypermethylation. Considering its novelty and its confirmed anti-silencing
phenotype, additional research is warranted to identify and characterize the mutation
in the rte1 mutant.
Although RTE1 was found by ros3 enhancer screening, the anti-silencing role of
RTE1 does not depend on ROS3. That inference is supported by the repressed trans-
gene expression and DNA hypermethylation phenotype in the rte1 single mutants.
Because rte1 mutant was obtained from ros3 enhancer screening, it is an rte1 and
ros3 double mutant. Comparing the luminescence phenotypes of the rte1 mutant
and the rte1 single mutant, we found that the luciferase transgene was more silenced
in the rte1 and ros3 double mutant than in the rte1 single mutant, indicating that
RTE1 and ROS3 have additive effects. We therefore suspect that RTE1 may function
in parallel with or downstream of ROS3.
ROS3 is a small, RNA-binding protein and is co-localized with ROS1 [5]. A pre-
vious report suggested that DNA demethylation by ROS1 may be guided by RNAs
bound to ROS3 [5]. Therefore, if RTE1 functions in a parallel pathway of ROS3,
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RTE1 could be a protein that interprets epigenetic markers, including specific his-
tone modifications or cytosine modification. By recognizing specific epigenetic marks,
RTE1 may guide DNA demethylases, like ROS1, to their target loci. ROS1 removes
methylcytosine from the DNA backbone through its glycosylase/lyase activity. This
leaves a nucleotide gap, which must be refilled with an unmethylated cytosine by DNA
repair-related enzyme activities. If RTE1 functions downstream of ROS3, RTE1 could
be a DNA repair-related enzyme that works with ROS1 to perform DNA demethyla-
tion. However, the rte1 mutant was not sensitive to MMS (methyl methanesulfonate)
(data not shown), which is a chemical that damages DNA. It follows that if RTE1
is an enzyme, it is probably a methyl-cytosine-specific rather than a general DNA
repair factor.
As noted, rte1 was isolated through an enhancer genetic screening for anti-silencing
factors. Our results suggest that RTE1 is a previously unknown component involved
in anti-silencing and in preventing DNA hypermethylation. Additional research is
required to determine which gene is responsible for the silencing phenotype of the
rte1 mutant. The further characterization of the rte1 mutant should increase our
understanding of how active DNA demethylation is regulated in plants, and may also
provide clues regarding the regulatory mechanisms of active DNA demethylation in
mammals.
3.5 Material and methods
3.5.1 Plant materials and growth conditions
All plants were Arabidopsis in the C24 genetic background. C24-luc plants con-
tain transgenes, including 35S promoter-driven NPTII (pro35S: NPTII) and RD29A
promoter-driven LUC (proRD29A:LUC ). Seeds were disinfested in 50% (vol/vol)
bleach for 15 minutes and then washed five times with sterilized water. After strat-
ification at 4C for 48 h, the seeds were plated on
1
2
MS medium. Plants were grown
at 23C in a growth chamber with 16 h of light and 8 h of darkness. Kanamycin
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sensitivity was tested on
1
2
MS with 50 mM kanamycin for 2 weeks. Cold stress was
imposed by exposure to 4C for 24 h. Salt stress was imposed by exposure to a 300
mM NaCl solution.
3.5.2 Mutant screen
For screening ros3 enhancer mutants, ros3 seeds were mutagenized with ethyl
methanesulfonate (EMS). Roughly 20000 individual lines from the M2 population
were used for screening ros3 enhancer mutants. The seeds were plated on MS medium
with C24-LUC and ros3 as controls. Seedlings were grown for 12 days, and exposed
to cold treatment (4C for 24 h) to induce LUC expression. After cold treatment, 1
mM luciferin, the substrate of luciferase, was sprayed on the surface of the 12-day-
old seedlings. Then the seedlings were placed in a dark chamber equipped with a
CCD camera (charged couple device). Five minutes of exposure time was used to
detect the emission of light from the seedlings. With the above screening, about 500
seedlings with reduced LUC emission compared to ros3 were chosen and transferred
from MS plates to soil. The seeds of individual lines were harvested separately. Lower
induced luminescence emission of these putative mutant lines was confirmed by using
the same method described earlier in the paragraph. After one round of confirmation,
the number of putative lines was reduced to 62. For these 62 putative lines, another
round of confirmation was performed. Through two rounds of tests, the phenotype
of one enhancer mutant, referred to as rte1, was confirmed.
3.5.3 Real-Time PCR
Total RNA was extracted with Trizol reagent (Ambion, cat#15596-026) from 12-
day-old seedlings following the manufacturer’s instructions, DNA contamination was
removed from the total RNA using the Turbo DNase (Ambion, cat#AM2238) kit. A
10-μg quantity of total RNA was treated with 1 μl of DNase I in a 20-μl reaction for 30
min at 37C, and then the reaction was stopped by treatment with 2 μl of inactivation
102
reagent for 5 min at room temperature. Reverse transcription was performed with
1 μg of RNA and oligo dT primers using the qScript cDNA SuperMix kit (Quanta,
cat# 95048-025). Then, 1 μl of cDNA was used as template in each qPCR reaction.
Real-time PCR were carried out on a BIO-RAD machine and using PerfeCTa SYBR
Green FastMix (Quanta, cat# 95072-250). ACTIN was used as an internal control.
3.5.4 Chop-PCR
Genomic DNA was extracted from 12-day-old mutants and wild-type seedlings.
After RNase (invitrogen) treatment at 37C for 1 h, DNA was purified with pheno-
chloroform-isopropyl (Thermo, cat# 17909) and precipitated by 2V ethanol and
1/10V NaOAC (3 M, pH 5.2). In a 30-μl reaction, methylation-sensitive enzymes
were used to digest 500 ng of DNA for 16 h, and 2 μl was used for PCR amplification.
3.5.5 Individual-locus bisulfite sequencing
The DNeasy Plant Mini Kit (QIAGEN) was used to extract genomic DNA from
3-week-old seedlings. According to the manufacturer’s protocol, the BisulFlash DNA
Modification Kit (Epigentek) was used to convert 200 ng of genomic DNA with sodium
bisulfite. For each 20-μl PCR reaction, 2 μl of bisulfite-treated DNA was used. The
Wizard SV Gel and PCR Clean-Up system (Promega) were used to purify PCR
products, which were later subcloned into the T-easy vector (Promega) following
the manufacturer’s protocol. Twenty independent clones were sequenced from each
genetic background to calculate the methylation level.
3.5.6 Whole-genome bisulfite sequencing
Genomic DNA was extracted from 12-day-old seedlings of the rte1 single mu-
tant #12 and wild-type plants. The bisulfite-sequencing library was constructed and
sequenced by the Purdue Genomics Core Facility.
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3.7 Figures and tables
Fig. 3.1. Luminescence phenotype of the rte1 mutant.
(A) Luminescence phenotype of 12-day-old seedlings. After 12-day-
old seedlings were treated at 4C for 24 h, their luminescence signals
were assessed. A luminescence signal was not observed in rte1 or in
the positive control, ros1-1. The diagram on the right indicates the
position of the different seedlings.
(B) Luminescence phenotype of 3-week-old seedlings. Three-week-old
seedlings were placed on a plate containing a 300 mM NaCl solution
and then were kept at 4C for 6 h. The luminescence signal was weaker
for rte1 than for ros3. The diagram on the right indicates the position
of the different seedlings.
(C) Luminescence phenotype of mature leaves following both cold and
salt treatment. For C24-luc or each mutant, three pieces of leaves
were taken from mature plants. The stress treatment was same as
described in (B). The luminescence phenotype of mature leaves was
consistent with that of 12-day-old and 3-week-old seedlings.
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Fig. 3.2. Silencing of RD29A promoter-driven transgenic and endoge-
nous genes in the rte1 mutant.
(A, B) Transcript levels of LUC and RD29A in the wild type, ros1-1,
ros3, and rte1. RNA from 12-day-old seedlings was used for qRT-
PCR. Plants was treated at 4C for 24 h to induce the expression of
transgenic and endogenous genes. Both transgenic (LUC ) and en-
dogenous (RD29A) genes driven by the RD29A promoter were sup-
pressed in the rte1 mutant.
(C) Cold-induced expression level of the control gene, COR15A. RNA
extraction and cold treatment were the same as described in (A, B).
COR15A was well induced in all tested plants, indicating an effective
cold treatment.
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Fig. 3.3. Silencing of the 35S promoter-driven NPTII transgene in
the rte1 mutant.
(A) Kanamycin resistance phenotype of rte1 mutant. Kanamycin re-
sistance was assessed on
1
2
MS medium containing 50 M kanamycin.




sensitivity was much greater in rte1 than in ros3 or C24-luc.
(B) Expression level of NPTII. RNA from 12-day-old seedlings was
used for qRT-PCR. The expression of NPTII was completely re-
pressed in rte1 and ros1, while some transcripts were detected in ros3.
The results were consistent with the kanamycin-resistant phenotype.
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Fig. 3.4. Examination of the rte1 methylation status using Chop-
PCR.
Chop-PCR was performed for each mutant and the wild type with four
biological replicates. For each reaction, an equal amount of genomic
DNA was digested by methylation-sensitive restriction enzymes. Bs-
mAI was used for the endogenous RD29A promoter marker. BstUI
was used for markers at transgenic RD29A promoter and At4g18650
promoter. HhaI was used for the Pm36 marker. ACTIN2 served as a
non-digestion control.
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Fig. 3.5. Methylation level of the RD29A promoter region in the rte1
mutant.
(A) A diagram showing the bisulfite sequencing mechanism. “C”
refers to unmethylated cytosine, while “mC” refers to methylated cy-
tosine. The unmethylated DNA is displayed above, and the methy-
lated DNA is displayed below. “U” in red represents the uracil con-
verted from unmethylated cytosine. In the PCR reaction, adenine
(A) will be paired with uracil (U).
(B) Methylation level of the RD29A promoter region. Endogenous
and transgenic RD29A promoters were not differentiated in this anal-
ysis. ros1-1 served as a positive control.
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Fig. 3.6. Isolation of rte1 single mutants.
(A) Luminescence phenotype of mature leaves of rte1 single mutants.
Two to three leaves are displayed for each mutant or the wild type.
Two individual lines of rte1 single mutants were selected, including
rte1 single mutant #12 and rte1 single mutant #19. LUC gene ex-
pression was induced by a 6-h exposure to a 300 mM NaCl solution
at 4C.
(B) Luminescence phenotype of seedlings of the rte1 single mutant.
Twelve-day-old seedlings were used to check the luminescence pheno-
type. LUC gene expression was induced by a 24-h cold treatment (at
4C).
110
Fig. 3.7. Kanamycin-resistance phenotype of the rte1 single mutant.
C24-luc served as a negative control, and ros1-1 served as a positive




ing 50 mM kanamycin. Fourteen-day-old seedlings of the rte1 single
mutant #12 were more sensitive to kanamycin than C24-luc.
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Fig. 3.8. Methylation status of the RD29A promoter in the rte1 single
mutant #12.
(A) Examination of the Chop-PCR marker at the endogenous RD29A
promoter in the rte1 single mutant #12. Chop-PCR for the mutant
and wild type were performed with two biological replicates. BstUI
was used for endogenous RD29A promoter marker. ACTIN2 served
as a non-digestion control.
(B) Methylation status of the RD29A gene in the wild type, the ros1-
1 mutant, and the rte1 single mutant #12. The bisulfite sequencing
result is displayed as a screenshot of genome browser tracks. The
upper and middle lanes indicate the methylation status in C24-luc
and ros1-1, respectively. The lower lane indicates the methylation
status in the rte1 single mutant #12. Each orange bar represents a
methyl cytosine, and the height of the bar indicates the methylation
level of the single cytosine. RD29A gene was diagramed as above the
screenshot.
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Fig. 3.9. Analysis of the genome-wide DNA methylation status in the
rte1 single mutant #12.
(A) Hyper- and hypo-methylated DMRs in the rte1 single mutant
#12. Whole-genome bisulfide sequencing was performed using 12-
day-old seedlings. Using wild type plants as control, hyper- and hypo
methylated regions in rte1 single mutant #12 were determined.
(B) The composition of hypermethylated regions in the rte1 single
mutant #12. The percentage of each type (either TE, gene, or inter-
genic region) is indicated.
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Fig. 3.10. Screenshots showing endogenous hypermethylated regions
in the rte1 single mutant #12.
Total DNA methylation is labeled with an orange bars. CG methyla-
tion is labeled with a yellow bar. CHG methylation is labeled with a
blue bar. CHH methylation is labeled with a pale pink bar. Each bar
represents a methyl cytosine, and the height of the bar indicates the
methylation level of the single cytosine. For each type of methylation,
the methylation status of C24-luc is displayed in the upper lane, and
the methylation status of the rte1 single mutant #12 is displayed
in the lower lane. The position of each region is labeled above the




Rough mapping of the rte1 mutant.
rte1 was crossed with Col-0. In the F2 population, seedlings with an
abnormal luminescence phenotype were selected and were genotyped
for the presence of proRD29A-LUC. Ninety-six seedlings were used for
the rough mapping of rte1 mutants. The SSLP markers were named
with three digits indicating the position of the marker (e.g. 416 is the
SSLP marker near 16Mbp on Chr.4).
Rough mapping of rte1 mutant
Chr.1 102 108 113 119 127
Ratio of Col-0 alleles to total alleles 52% 49% 53% 52% 46%
Chr.2 203 210 214 218
Ratio of Col-0 alleles to total alleles 48% 50% 54% 57%
Chr.3 301 312 319
Ratio of Col-0 alleles to total alleles 46% 50% 43%
Chr.4 401 406 408 409 416 418
Ratio of Col-0 alleles to total alleles 25% 20% 20% 20% 28% 25%
Chr.5 509 515 522
Ratio of Col-0 alleles to total alleles 51% 50% 61%
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4. SUMMARY
In this study, we designed two genetic screens to identify new anti-silencing factors
which may be involved in DNA demethylation and prevention of transcriptional gene
silencing. One genetic screen is based on the stress inducible RD29A promoter fused
with the firefly luciferase reporter gene (RD29A::LUC ), and the second genetic screen
is based on cauliflower mosaic virus 35S promoter-driven SUC2 (35S::SUC2 ) trans-
gene. Using these two systems, we identified two new anti-silencing factors, MBD7
and RTE1. MBD7 is a methyl-CpG-binding protein. MBD7 is required for the proper
expression of the 35S::SUC2 transgene by preventing DNA hypermethylation at 35S
promoter region. In addition, thousands of DMRs have been identified in mbd7-1
mutants through whole genome bisulfite sequencing, supporting the role of MBD7 in
preventing genome-wide DNA hypermethylation. Using ChIP-seq assays, we found
that MBD7 binding is correlated with CG methylation density. The MBD7 binding
to its genomic targets is associated with its anti-silencing role.
From the RD29A::LUC system, RTE was identified as a putative new anti-
silencing factor. RTE1 is required for the proper expression of the RD29A::LUC
transgene by preventing DNA hypermethylation at the RD29A promoter region.
Whole genome bisulfite sequencing results revealed that RTE1 is required for pre-
venting DNA hypermethylation at hundreds of genomic loci. Due to difficulties as-
sociated with the complex and sometimes unstable silencing of the RD29A::LUC in
the mapping population generated from crosses between C24 rte1 and Col wild type,
we have not been able to precisely map the rte1 mutation to identify the responsible
gene for the siliencing of RD29A::LUC in the rte1 mutant. Further efforts are needed
in order to identify the RTE1 gene in the future.
Two types of anti-silencing factors can be found from these two genetic screens:
components required for prevention of silencing of both RD29A and 35S promoters
116
and components required for prevention of silencing of only the 35S promoter. For
examples, the ros1 mutant was first identified using the RD29A::LUC system, and
recenlty more alleles of ros1 mutants were isolated from the 35S-SUC2 systems.
Therefore, ROS1 is required for the anti-silencing of both the RD29A::LUC and
35S::SUC2 transgenes. Unlike ROS1, IDM1 and IDM2 are only required for the
anti-silencing of 35S::SUC2 and 35S::NPTII, but not required for the anti-silencing
of RD29A::LUC , suggesting that different mechanisms exist for the anti-silencing of
the transgenic RD29A promoter and transgenic 35S promoter.
Based on this study and previous studies, the two genetic screening systems ap-
pear to have the following similarities. First, in the RD29A::LUC system, mul-
tiple copies of the RD29A:LUC transgenes are inserted into the genome. In the
35S::SUC2 system, there are three transgenes which are 35S::SUC2, 2x35S::NPTII,
and 2x35S::HPTII. Therefore, multiple copies of the 35S promoter exist in the WT
plants. Second, at the promoter regions of both RD29A::LUC and 35S::SUC2, there
are high levels of DNA methylation in wild type plants, although the methylation is
still insufficient to cause transgene silencing. In the anti-silencing mutants, the high
level DNA methylation spreads to the neighboring regions and the spreading causes
the silencing of RD29A::LUC and 35S::SUC2.
The two systems also have important differences. This difference may help us
understand why different factors are required for the silencing of transgenic RD29A
and 35S promoters, respectively. Although high levels of DNA methylation exist at
both the RD29A and 35S promoter regions in wild type plants, the types of DNA
methylation at these two promoters regions are different. At the RD29A promoter,
DNA methylation mainly occurs in the CHG and CHH sequence contexts. In contrast,
the DNA methylation at the 35S promoter region is mostly CG methylation. The
MBD7 binding to the target loci is correlated with the CG methylation density but
not with CHG and CHH methylation densities as shown in Chapter 2. MBD7 binding
to the 35S promoter appears to be due to the high CG methylation density at the
35S promoter region, whereas the transgenic RD29A promoter does not seem to have
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enough CG density to allow MBD7 binding. In summary, through the genetic screens
we found two new anti-silencing factors, and our characterization of the mbd7 and
rte1 mutants has contributed to a better understanding of active DNA demethylation
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